Abstract
Retromer, including Vps35, Vps26, and Vps29, is a protein complex responsible for recycling proteins within the endolysosomal pathway. Although implicated in both Parkinson’s and Alzheimer’s disease, our understanding of retromer function in the adult brain remains limited, in part because Vps35 and Vps26 are essential for development. In Drosophila, we find that Vps29 is dispensable for embryogenesis but required for retromer function in aging adults, including for synaptic transmission, survival, and locomotion. Unexpectedly, in Vps29 mutants, Vps35 and Vps26 proteins are normally expressed and associated, but retromer is mislocalized from neuropil to soma with the Rab7 GTPase. Further, Vps29 phenotypes are suppressed by reducing Rab7 or overexpressing the GTPase activating protein, TBC1D5. With aging, retromer insufficiency triggers progressive endolysosomal dysfunction, with ultrastructural evidence of impaired substrate clearance and lysosomal stress. Our results reveal the role of Vps29 in retromer localization and function, highlighting requirements for brain homeostasis in aging.
Research organism: D. melanogaster
Introduction
The endolysosomal membrane system comprises a dynamic network of interconnected compartments that mediates sorting or degradation of endocytosed proteins (Klumperman and Raposo, 2014; Repnik et al., 2013). Many factors that regulate endolysosomal trafficking are implicated in human disease, including neurodegenerative disorders (Small and Petsko, 2015; Soukup et al., 2018). Among these, retromer is a complex that recycles selected protein cargoes from the endosome to the trans-Golgi network or the plasma membrane (Burd and Cullen, 2014; Lucas and Hierro, 2017). Mutations in VPS35—encoding a retromer core protein—are a rare cause of familial Parkinson’s disease (Vilariño-Güell et al., 2011; Zimprich et al., 2011), and retromer has also been linked to endocytic trafficking and processing of the Amyloid Precursor Protein and Tau in Alzheimer’s disease (Muhammad et al., 2008; Vagnozzi et al., 2019; Wen et al., 2011). Despite its emerging importance in neurodegenerative disease, the requirements of retromer in neurons and particularly within the aging nervous system remain incompletely understood.
Originally discovered in the yeast Saccharomyces cerevisiae (Seaman et al., 1998), the heterotrimeric core proteins of the retromer, VPS35, VPS26, and VPS29, are highly conserved among eukaryotes (Koumandou et al., 2011). Retromer components are broadly expressed, including in the invertebrate nervous system (Inoshita et al., 2017; Wang et al., 2014) and throughout the mammalian brain (Appel et al., 2018; Tsika et al., 2014). In murine neurons, retromer is present in both axons and dendrites, and at the synapse (Munsie et al., 2015; Tsika et al., 2014). Post-synaptically, retromer appears important for trafficking of AMPA, β2 adrenergic, and perhaps other neurotransmitter receptors to the dendritic membrane (Choy et al., 2014; Munsie et al., 2015; Temkin et al., 2017). In rat mesencephalic cultures, retromer also participates in pre-synaptic dopamine transporter trafficking (Wu et al., 2017), and studies of Vps35 at the Drosophila neuromuscular junction suggest a requirement for synaptic vesicle recycling (Inoshita et al., 2017). Vps35-deficient mice exhibit both defective hippocampal neurotransmission (Muhammad et al., 2008) and dopaminergic insufficiency (Tang et al., 2015a; Tang et al., 2015b), leading to impairments in memory and locomotion, respectively.
Retromer regulates lysosomal degradation pathways, including autophagy, which are important for quality control and brain homeostasis (Martini-Stoica et al., 2016; Menzies et al., 2015). In the absence of retromer, many protein cargoes are misdirected to the lysosome (Burd and Cullen, 2014; Lucas and Hierro, 2017; Wang and Bellen, 2015), potentially overwhelming degradative capacity, leading to lysosomal expansion and cellular stress. For example, in the Drosophila retina, loss-of-function for Vps35 or Vps26 results in accumulation of the visual pigment, Rhodopsin-1 (Rh1), within photoreceptors, ultimately causing neuronal dysfunction and loss (Wang et al., 2014). Nevertheless, most investigations of the retromer in lysosomal function have relied on cell culture paradigms using non-neuronal cell types (Cui et al., 2019; Jimenez-Orgaz et al., 2018; Zavodszky et al., 2014). Ablation of VPS35 in the mouse germline is embryonic lethal (Wen et al., 2011), and both Vps35 and Vps26 similarly have essential developmental requirements in Drosophila (de Vreede et al., 2014; Franch-Marro et al., 2008; Pocha et al., 2011; Starble and Pokrywka, 2018; Strutt et al., 2019; Wang and Bellen, 2015).
Notably, among the retromer core proteins, the precise roles of each subunit remain incompletely defined, with especially scant data on VPS29. VPS29 binds the VPS35 C-terminus (Collins et al., 2005; Hierro et al., 2007; Kovtun et al., 2018). Deletion of Vps29 in yeast or Caenorhabditis elegans phenocopies Vps35 loss-of-function (Lorenowicz et al., 2014; Seaman et al., 1997). In mammalian epithelial cell culture, reducing VPS29 results in apparent destabilization and degradation of both VPS35 and VPS26 (Fuse et al., 2015; Jimenez-Orgaz et al., 2018). Reciprocally, pharmacological chaperones targeting the VPS35-VPS29 interface can stabilize the complex and enhance retromer function (Mecozzi et al., 2014; Young et al., 2018; Lin et al., 2018). Here, we have generated and characterized a Drosophila Vps29 null allele with a focus on in vivo requirements in the nervous system. We identify an unexpected requirement for Vps29 in the regulation of retromer localization, and further highlight a role in synaptic vesicle recycling and lysosomal function in the aging brain.
Results
Vps29 is required for age-dependent retinal function
Drosophila Vps29 is predicted to encode a 182 amino-acid protein that is 93% similar (83% identical) to human VPS29. Prior studies of Vps29 in flies have relied on RNA-interference knockdown approaches (Linhart et al., 2014). We instead generated a Vps29 null allele using a CRISPR-Cas9 strategy (Li-Kroeger et al., 2018). In the resulting mutant, Vps291, the entire coding sequence was replaced by the visible marker gene, ywing2+ (Figure 1A). Unexpectedly, Vps291 was homozygous viable, whereas both Vps35 and Vps26 mutants are lethal (Franch-Marro et al., 2008; Wang et al., 2014). Loss of the Vps29 genomic sequence in null animals was confirmed by PCR (Figure 1B) and sequencing of the insertional breakpoints, and we were not able to detect any protein using an anti-Vps29 antibody on western blots from fly head homogenates (Figure 1C). Although viable, Vps291 homozygotes are recovered at ratios below Mendelian expectation (Figure 1—figure supplement 1A). We also recovered viable Vps291 animals lacking both maternal and zygotic protein when crossing homozygous females to heterozygous males. Notably, Vps291 mutant flies exhibit a modestly reduced survival (~50–60 days versus ~75 days for controls), and this result was confirmed when Vps291 animals were crossed to the deficiency, Df(2L)Exel6004 (Figure 1D). The reduced survival seen in Vps29 null animals was also rescued by a 23 kb P[acman] bacterial artificial chromosome (Venken et al., 2009) containing the Vps29 genomic locus, establishing specificity.
Figure 1. Vps29 is required for age-dependent retinal function.
(A) The Vps29 genomic locus is shown, highlighting reagents used in this study. In the null allele, Vps291, the gene coding sequence (blue, 2L: 1150852–1151420) is replaced by a ywing2+ marker gene. Vps29WT.GFP and Vps29L152E.GFP are identical N-terminal tagged-Vps29 alleles, except for the L152E variant. A chromosomal deficiency Df(2L)Exel6004 is shown, with the deleted regions indicated by dashed lines. A bacterial artificial chromosome (BAC) (yellow) was used for transgenic genomic rescue (GR). (B) Genomic polymerase chain reaction (PCR) showing loss of Vps29 coding sequence in Vps291 homozygotes versus control (w) flies. P1, P2, and P3 denote expected PCR products from primer pairs targeting Vps29 genomic sequence. As an additional control, PCR was also performed for Vps35 genomic sequence. We also performed PCRs using primer pairs that span both sides of the breakpoint junctions abutting the inserted ywing2+ marker gene cassette (not shown), and these products were Sanger sequenced to confirm the depicted molecular lesion. (C) Western blot from adult heads probed with anti-Vps29 antibody, confirming Vps291 is a protein null allele. (D) Vps291 homozygotes and Vps291/Df transheterozygotes (Vps291/Df(2L)Exel6004) show reduced survival that is rescued by the Vps29 genomic rescue strain (Vps291/Df; GR/+). Quantitation based on n = 200–235 per group. See also Figure 1—figure supplement 1A. (E) Representative ERG traces at 1- and 10 days after generation of ey-FLP clones from (i) control (FRT40A), (ii) Vps291, or (iii) Vps35MH20. Flies were raised using an alternating 12 hr light/dark cycle (12h-LD) or in complete darkness. Loss of either Vps29 or Vps35 disrupted light-induced depolarization (arrow) in 10-day-old flies. On- and off- transient ERG potentials (top and bottom arrowheads, respectively) were also lost. Raising flies in the dark restored ERG depolarization, but not the transients, indicating persistent defects in synaptic transmission. (F–G) Quantification (n = 6–8) of ERG depolarization and on-transient potentials. ‘X’ denotes undetectable on-transients in 20-day-old animals. See also Figure 1—figure supplement 1B. (H) Compared with controls (FRT40A clones), ERG transient potentials are extinguished by rapid stimulation in Vps291 clones. Consistent results were obtained using either ey-FLP or ey3.5-FLP, which targets presynaptic neurons only. Flies were raised in complete darkness and examined at 1 day. See also Figure 1—figure supplement 1C. (I) Rescue of Vps291 synaptic transmission defects by pan-neuronal expression (nSyb-GAL4 driver) of either Drosophila Vps29 or Vps35 (dVps29 and dVps35) or human Vps29 (hVps29-1,−2, or −3, representing three alternate isoforms). Quantification of ERG on-transients in 15-day-old flies (n = 9–12 per group) from the following genotypes: (1) Vps291;nSyb-Gal4/+; (2) Vps291;nSyb-Gal4/UAS-dVps29; (3-5) Vps291;nSyb-Gal4/UAS-hVps29; and (6) Vps291;nSyb-Gal4/UAS-dVps35. Statistical analysis was based on log-rank test with Bonferroni's correction (D) or one-way ANOVA (F, G, I). All error bars denote SEM. n.s., not significant; **, p<0.01; ***, p<0.001.
Figure 1—figure supplement 1. Additional studies of the adult retina.
As introduced above, the retromer plays an essential role in the endocytic recycling of Rh1 in the Drosophila eye, thereby enabling proper phototransduction (Wang et al., 2014). Consequently, loss of either Vps35 or Vps26 leads to aberrant Rh1 trafficking, resulting in lysosomal stress and progressive retinal degeneration. In order to determine if Vps29 is similarly required, we generated somatic clones of either Vps291 or the Vps35MH20 null allele in the fly eye using the eyeless (ey)-FLP/FRT system (Newsome et al., 2000), and monitored degeneration using electroretinograms (ERGs). Compared with control clones (FRT40A), removing either retromer component from photoreceptors disrupted light-induced depolarization in 10-day-old animals; however, the Vps29 phenotype was less severe than that due to loss of Vps35 (Figure 1E,F). Consistent with other retromer components, the Vps291 retinal degeneration phenotype was suppressed when flies were raised in the dark, which eliminates phototransduction and the concomitant endocytosis of Rh1. Age- and light-dependent retinal degeneration in the absence of Vps29 was further confirmed by histology (Figure 1—figure supplement 1B), and this phenotype was also reversed by introduction of the Vps29 genomic rescue construct. On further inspection of the ERG traces, we noticed that both Vps291 and Vps35MH20 appear to disrupt synaptic transmission (Figure 1E,G), based on progressive reduction in the on- and off-transient potentials in aging animals (Babcock et al., 2003). Interestingly, however, whereas raising animals in the dark rescued phototransduction, the ERG transient potential phenotypes persisted, suggesting a role for retromer at the synapse that is independent of Rh1 recycling.
In our ERG experiments, we also noticed that whereas the transient potentials are preserved in newly eclosed animals with Vps29 or Vps35 mutant eye clones, they were poorly sustained throughout the recordings. We therefore repeated our ERG experiments in retinae with either Vps291 or Vps35MH20 mutant clones, but instead using a rapid light stimulation paradigm. Indeed, we documented a progressive decline in the on- and off-transient potentials following rapid stimulation, and consistent results were also obtained using the ey3.5-FLP driver (Mehta et al., 2005), which selectively targets presynaptic neurons (Figure 1H and Figure 1—figure supplement 1C). This ‘run-down’ phenotype is characteristic of mutants that disrupt synaptic vesicle recycling (Harris and Littleton, 2015), suggesting that retromer is required for this process. We further demonstrated that the retinal synaptic transmission phenotype in Vps291 homozygotes was fully rescued using the pan-neuronal expression driver (nSyb-GAL4) and a full-length Drosophila Vps29 cDNA (nSyb>Vps29) (Figure 1I). Finally, similar rescue was observed when expressing three alternate human Vps29 isoforms, consistent with functional conservation. Surprisingly, we also found that pan-neuronal overexpression of Vps35 (nSyb>Vps35) partially restored synaptic transmission in Vps291 homozygous animals. In combination with the somewhat weaker phenotype, this result suggests that Vps29 may function primarily to potentiate the activity of other retromer subunits in the retina, such that Vps35 overexpression is compensatory. In sum, whereas Vps29 appears dispensable for retromer function during embryogenesis and development, these studies reveal a requirement in the aging nervous system for phototransduction and synaptic transmission.
Retromer regulates synaptic vesicle endocytosis and recycling
To further explore the requirement of retromer at synapses, we next turned to the larval neuromuscular junction (NMJ). Based on previous work, Vps35 is present at both the NMJ pre- and post-synapse, and loss of Vps35 causes synaptic terminal overgrowth and altered neurophysiology suggestive of synaptic vesicle recycling defects (Inoshita et al., 2017; Korolchuk et al., 2007; Malik et al., 2015; Walsh et al., 2019). We therefore examined whether Vps29 mutants show similar phenotypes. Indeed, NMJ preparations from Vps291 homozygous larvae revealed a modest but significant increase in synaptic bouton numbers, consistent with synaptic overgrowth (Figure 2A). However, both amplitude and frequency of NMJ miniature excitatory junction potentials (mEJPs) were unaffected following loss of Vps29 (Figure 2B). Similarly, excitatory junction potentials (EJPs) were also preserved (Figure 2C). These results suggest that Vps29 is neither required for spontaneous nor evoked synaptic vesicle release. However, high-frequency stimulation (10 Hz for 10 min) provoked a marked synaptic depression at the Vps291 NMJ (Figure 2D). These data provide further support for the role of Vps29 in synaptic vesicle recycling.
Figure 2. Retromer regulates synaptic vesicle endocytosis and recycling.
(A) Vps29 loss of function causes an increased number of synaptic terminal boutons at the larval neuromuscular junction (NMJ). NMJ preparations from Vps291 homozygotes or control larvae (GR = Vps291;GR/+) were stained with an antibody against horseradish peroxidase, and Type IIb boutons at abdominal segments A2 and A3 were quantified (n = 5 animals per group). The Vps29 transgenic BAC (GR) was heterozygous for all comparisons. (B) Larval NMJ electrophysiology in Vps291 reveals normal miniature excitatory junction potential (mEJP) amplitude and frequency (in 2 min) (n = 14–16). (C) Evoked excitatory junction potentials (EJPs) are normal in the absence of Vps29. Representative EJP traces from Vps291 and Vps291;GR/+ (control, GR) larvae and quantification (n = 13–15). 0.2 Hz stimulation was performed using 0.5 mM Ca2+. (D) Vps291 NMJs show synaptic depression following rapid stimulation (10 Hz, 0.5 mM extracellular Ca2+). Representative traces (10 min) are shown, with quantification (n = 13). Data was normalized to initial EJP amplitude. (E) Vps291 NMJs show reduced FM 1-43 dye uptake following KCl stimulation, consistent with impaired synaptic vesicle endocytosis. FM1-43 signal intensity (per bouton area) was quantified (n = 8–11). See also Figure 2—figure supplement 1. Statistical analysis (A–E) based on Student’s t-test. All error bars denote SEM. n.s., not significant; *, p<0.05; ***, p<0.001.
Figure 2—figure supplement 1. Additional studies of the neuromuscular junction.
The NMJ synaptic run-down phenotype is characteristic of mutants causing defective endocytosis (Bellen et al., 2010; Verstreken et al., 2002; Winther et al., 2013). To further investigate if synaptic vesicle endocytosis requires the retromer, we performed dye uptake studies in animals lacking Vps29 or Vps35 (Figure 2E and Figure 2—figure supplement 1). Larval preparations were stimulated with potassium chloride in the presence of extracellular buffer containing the fluorescent dye FM 1–43, permitting quantification of endocytic flux (Verstreken et al., 2008). In control animals, FM 1–43 dye was rapidly internalized at the presynaptic membrane. However, NMJs from either Vps291 or Vps35MH20 homozygous animals significantly reduced FM dye uptake. These results are consistent with models whereby retromer either directly or indirectly supports vesicle recycling at the presynapse.
Vps29 regulates retromer localization and is required in the aging nervous system
The requirement of retromer during Drosophila embryogenesis has hindered systematic characterization of its function in the adult nervous system, with the exception of studies in the retina relying on clonal analysis of Vps35 and Vps26 (Wang et al., 2014). Although Vps29 is dispensable for embryonic development, our results (above) establish a largely conserved Vps29 requirement for retromer function in the retina and at the NMJ synapse. We therefore studied Vps29 null adult animals to further explore retromer requirements in the adult brain. Except for the aforementioned retinal requirement, we did not observe obvious morphological defects or apparent evidence of neurodegeneration in the brains of 45-day-old Vps291/Df adults based on hematoxylin and eosin staining of paraffin sections (Figure 3—figure supplement 1A). In order to examine nervous system function, we next tested the startle-induced negative geotactic response (climbing) (Davis et al., 2016; Rousseaux et al., 2018). Although locomotor behavior was normal in newly eclosed Vps29 null adults, climbing ability significantly declined with aging (Figure 3A). Our results are consistent with published work using RNA-interference to target Vps29 (Linhart et al., 2014). Vps291 homozygous flies manifested a stronger locomotor dysfunction phenotype than Vps291/Df, suggesting the presence of a potential modifier; however, both genotypes were fully rescued by the genomic BAC transgene. Similar results were obtained for the Vps29 retinal degeneration phenotype (Figure 1—figure supplement 1B). Locomotor defects in Vps291 homozygous animals were also partially rescued by pan-neuronal Vps29 expression (nsyb>Vps29), and human VPS29 showed comparable rescue activity (Figure 3B). Overall, these results suggest Vps29 is required for the maintenance of nervous system function in aging animals.
Figure 3. Progressive locomotor impairment in Vps29 mutants but preserved Vps35 and Vps26 protein levels.
(A) Vps291/Df and Vps291 adults demonstrate age-dependent locomotor impairment, based on startle-induced negative geotaxis, and this phenotype is fully rescued by a single, heterozygous copy of the Vps29 BAC transgenic (Vps291/Df; GR/+ and Vps291; GR/+). Control: yw/w. The Vps291 homozygote genotype manifests a stronger locomotor phenotype than Vps291/Df (p<0.01 in comparisons at 20 days). Quantification based on n = 4 groups, each consisting 14–16 flies. See also Figure 3—figure supplement 1A. (B) Pan-neuronal expression of either Drosophila or human Vps29 (dVps29 or hVps29, respectively), using the nsyb-GAL4 driver rescues the Vps291 locomotor phenotype. Quantification based on n = 4 groups of 20-day-old flies from the following genotypes: (1) Vps291;nSyb-Gal4/+; (2) Vps291;nSyb-Gal4/UAS-dVps29; and (3-5) Vps291;nSyb-Gal4/UAS-hVps29. (C) Vps35 and Vps26 protein levels are normal in the absence of Vps29. Western blots of adult fly head homogenates from either Vps291, Vps35GFP homozygotes or controls (Vps35GFP), probed for Vps35GFP (anti-GFP), Vps26, or Tubulin (loading control). Quantification based on n = 3 replicate experiments. See also Figure 3—figure supplement 1B,C. (D) The association of Vps35 and Vps26 proteins is preserved in the absence of Vps29. Vps35GFP was immunoprecipitated from either Vps291, Vps35GFP homozygotes or control animals (Vps35GFP) (2 day old), and western blots were probed for Vps35GFP (anti-GFP), Vps26, and Vps29. Quantification based on n = 4 replicate experiments. Statistical analysis based on one-way ANOVA (A–C) or Student’s t- test (D). All error bars denote SEM. n.s., not significant; **, p<0.01; ***, p<0.001.
Figure 3—figure supplement 1. Loss of Vps29 does not affect Vps35 or Vps26 protein expression.
In prior studies of HeLa cell cultures, VPS29 knockdown caused reduced levels of both VPS35 and VPS26, likely due to destabilization of the retromer trimer complex and subunit turnover (Fuse et al., 2015; Jimenez-Orgaz et al., 2018). Reciprocally, enhancing interactions between VPS29 and VPS35 promotes retromer stability (Mecozzi et al., 2014; Young et al., 2018). However, Vps35 and Vps26 protein levels were unaffected in Vps29 null animals (either Vps291 homozygotes or Vps291/Df), based on western blots from either whole larvae or adult Drosophila heads (Figure 3C and Figure 3—figure supplement 1B,C), including from 30-day-old animals. Furthermore, we confirmed that Vps35 and Vps26 remain tightly associated in the absence of Vps29, based on coimmunoprecipitation assays (Figure 3D). Thus, Vps35-Vps26 complex assembly and stability in the nervous system are preserved in Drosophila lacking Vps29.
Besides expression and stability, retromer function is tightly regulated by its subcellular localization (Follett et al., 2016; Lucas et al., 2016). We examined retromer expression and localization in the adult fly brain using endogenously tagged fluorescent protein alleles, encoding either Vps35RFP or Vps35GFP (Koles et al., 2016), as well as Vps29GFP (Figure 1A) fusion proteins. As expected, Vps29 and Vps35 appeared to colocalize, and were broadly expressed in the Drosophila brain, including the antennal lobes and the mushroom body (α-/β- lobes and peduncles) (Figure 4A,B). We confirmed that most of the observed staining in the adult brain, including within neuropil regions, derived from neuronal Vps35, as this signal was lost following neuronal-specific knockdown (Figure 4—figure supplement 1A). However, in Vps291 homozygous animals, Vps35 showed a striking redistribution, shifting from neuropil to enrichment in soma, and forming large perinuclear puncta (Figure 4C). Moreover, Vps35 was mislocalized in brains from 1-day-old adults and this result did not significantly change with aging. Consistent results were obtained in the lamina, where retinal photoreceptors synapse on second-order neurons in the visual pathway (Figure 4—figure supplement 1B). Specifically, in Vps291 homozygotes, both Vps35 and Vps26 accumulated in the lamina cortex and staining was attenuated in the lamina neuropil. Lastly, we also found that Vps35 was depleted from the Vps291 homozygous larval brain neuropil and at the NMJ synaptic bouton; however, we did not detect any apparent enrichment in motor neuron cell bodies (Figure 4—figure supplement 2). Overall, these data suggest that Vps29 is required for normal retromer localization within neurons.
Figure 4. Vps29 regulates Vps35 localization in the adult brain.
(A) Vps29GFP (anti-GFP, green) and Vps35RFP (red) are expressed throughout the adult brain and co-localize. Boxed region of interest including antennal lobe (top row) is shown magnified (bottom row). Representative puncta (arrowhead) co-staining for Vps35 and Vps29 is further magnified in inset. Scale bars, 100 µm. (B) Vps35GFP (anti-GFP, green) is modestly enriched in neuropil regions, including the antennal lobes and the mushroom body (α-/β- lobes and peduncles). Scale bars, 100 µm. See also Figure 4—figure supplement 1A. (C) In the absence of Vps29, Vps35GFP (green) protein is redistributed in the adult brain, shifting from neuropil to soma and forming large perinuclear puncta. Neuronal nuclei are labeled with anti-Elav (red). Within the boxed region of interest, including antennal lobe and surrounding nuclei, the GFP intensity ratio (perinuclear to neuropil) was quantified (n = 3) in Vps291, Vps35GFP homozygotes or Vps35GFP controls. Scale bars, 100 µm. See also Figure 4—figure supplement 1B and Figure 4—figure supplement 2. (D) Schematic highlighting the Rab7 cycle including GTP-bound (active) and GDP-bound (inactive) forms and putative interactions regulating retromer recruitment and release. (E) In Vps29 mutants, Vps35GFP (green) colocalizes with Rab7 (anti-Rab7, red), which appears increased and similarly redistributed from neuropil to soma. The region of interest centered on the antenna lobe is indicated in the boxed region of the lower power image (maximal intensity projection); the magnified images are representative anterior single sections taken through the antennal lobe. Scale bars, 100 µm. See also Figure 4—figure supplement 3. (F) Rab7 protein levels are increased in the absence of Vps29. Western blots of adult head homogenates, including Vps291, Rab7EYFP homozygotes or Rab7EYFP controls (2-day-old), were probed for Rab7-YFP (anti-GFP) and Tubulin (loading control). Quantification based on n = 4 replicate experiments. See also Figure 4—figure supplement 4A. (G) Rab7 protein levels are increased in the constitutive active, ‘GTP-locked’ Rab7Q67L mutant. Western blots of adult head homogenates from 5-day-old animals were probed for Rab7 or Actin, including the following genotypes: (1, Rab7-Gal4 > Rab7 CA) UAS-Venus-Rab7 Q67L/+; Rab7-Gal4/+; (2, Rab7-Gal4 > Rab7 WT) UAS-Venus-Rab7 WT/+; Rab7-Gal4/+; (3, Rab7-Gal4 > Rab7 DN) UAS-Venus-Rab7 T22N/+; Rab7-Gal4/+; (4, control) w. Venus-tagged or endogenous Rab7 protein levels were separately quantified, based on n = 4 replicate experiments. See also Figure 4—figure supplement 4B. Statistical analysis was based on Student’s t-test (C, F) or one-way ANOVA (G). To address the possibility of a modestly skewed distribution, the data in C were log2-transformed, and the results of t-tests were unchanged. All error bars denote SEM. *, p<0.05; **, p<0.01.
Figure 4—figure supplement 1. Loss of Vps29 causes mislocalization of retromer in adult brain.
Figure 4—figure supplement 2. Loss of Vps29 causes mislocalization of Vps35 in larvae.
Figure 4—figure supplement 3. Loss of Vps29 causes mislocalization of Rab7.
Figure 4—figure supplement 4. Increased Rab7 expression following loss of Vps29.
Vps29 interacts with Rab7 and TBC1D5
Based on cell culture studies, Vps35 is recruited to endosomal membranes by the Rab7 GTPase (Seaman et al., 2009), and VPS29 knockdown has been previously suggested to increase GTP-bound, activated Rab7 (Jimenez-Orgaz et al., 2018). We therefore examined whether dysregulation of Rab7 may similarly participate in neuronal retromer localization in vivo (Figure 4E–G and Figure 4—figure supplement 3). Indeed, in the adult brain of Vps291 homozygotes, the Rab7 signal appeared strongly increased and was restricted to a somatic, perinuclear pattern with relative depletion from neuropil. The Arl8 GTPase, which functions coordinately with Rab7 in endolyososmal maturation (Jongsma et al., 2020; Marwaha et al., 2017), was increased in a similar pattern in the Vps291 adult brain. Based on prior studies (Lund et al., 2018; Rosa-Ferreira et al., 2018), Arl8 localizes to the lysosomal membrane, and we confirmed this using an independent lysosomal marker, Spinster-GFP (Sweeney and Davis, 2002). Importantly, mislocalized Vps35 strongly costained with perinuclear Rab7 and Arl8, suggesting enrichment at the late endosome and/or lysosome. On western blots, we documented an increase in Rab7 protein in either Vps291 homozygotes or Vps291/Df (Figure 4F and Figure 4—figure supplement 4A). To examine if the change in Rab7 expression level reflects an altered ratio of GTP-bound (active) to GDP-bound (inactive) Rab7 protein (Figure 4D), we leveraged available fly strains harboring Venus-tagged Rab7 transgenes (Cherry et al., 2013), including wildtype Rab7, the ‘GTP-locked’ mutant Rab7Q67L and the ‘GDP-locked’ mutant Rab7T22N, under the control of identical Rab7 promoter elements (Rab7-GAL4). We found that the constitutively active, GTP-locked Rab7Q67L protein was present at higher levels (Figure 4G and Figure 4—figure supplement 4B). Moreover, endogenous wildtype Rab7 was also increased, potentially reflecting a compensatory cellular response. These data support a model in which loss of Vps29 promotes Rab7 activation, redistribution of active Rab7 from axon to soma, and subsequent recruitment of Vps35.
If Rab7 activation mediates the disruption in retromer localization and function in Vps29 mutants, our model predicts that reduction in Rab7 may rescue the neuronal requirements for Vps29. Indeed, although complete loss-of-function for Rab7 is lethal, removing one copy (Rab7Gal4-KO/+) (Cherry et al., 2013) partially rescued the age-dependent locomotor impairment and synaptic transmission defects manifest in Vps291/Df animals (Figure 5A,B). Reduction of Rab7 also restored synaptic vesicle endocytosis at the larval NMJ in Vps291 homozygotes, based on the FM 1–43 dye uptake assay (Figure 5C). In mammalian cell culture studies, VPS29 regulates Rab7 activity via recruitment of the GTPase-activating protein (GAP), TBC1D5 (Jia et al., 2016; Seaman et al., 2009). Drosophila has a single ortholog of TBC1D5 that is well-conserved (28% identity/47% similarity) (Gramates et al., 2017). Consistent with our model, pan-neuronal overexpression of dTBC1D5 (nsyb>dTBC1D5) normalized Rab7 protein levels (Figure 5D) and partially rescued the synaptic transmission defect in Vps29 mutants (Figure 5E). Next, we introduced a point mutation at the Vps29 genomic locus causing the single amino-acid substitution, Vps29L152E (Figure 1A); mutation of this conserved residue has been shown to disrupt the interaction with TBC1D5 in mammalian cells (Jia et al., 2016; Jimenez-Orgaz et al., 2018). Vps29L152E failed to complement Vps291 (Figure 5F–H and Figure 5—figure supplement 1), causing age-dependent photoreceptor synaptic transmission defects and locomotor impairment. The residual, albeit weak on-transient ERG potential in Vps291/Vps29L152E adults suggest that Vps29L152E is a hypomorphic allele. Moreover, Vps29L152E was expressed at higher levels and Rab7 was also increased, as in Vps291. Overall, these results indicate that Vps29 regulates retromer localization coordinately with Rab7 and TBC1D5.
Figure 5. Reduction of Rab7 or overexpression of TBC1D5 suppresses Vps29 mutant phenotypes.
(A–C) Reduction of Rab7 rescues Vps29 mutant phenotypes, including progressive locomotor impairment (A), synaptic transmission (B), and synaptic vesicle endocytosis at the larval NMJ (C). (A) Quantification of locomotor behavior based on n = 4 groups, each consisting of 12–15 flies. (B) Quantification of electroretinogram (ERG) on-transients (n = 12–13) from adults raised using a 12 hr light/dark cycle. (C) FM 1-43 dye uptake signal intensity per NMJ bouton area was quantified (n = 7–9). (D) Pan-neuronal overexpression of dTBC1D5 (nsyb>dTBC1D5) restores Rab7 protein level in flies lacking Vps29. Western blots of adult fly head homogenates (30-day-old) were probed for Rab7 and Tubulin (loading control), and quantified based on n = 4 replicate experiments, including the following genotypes: (1, red) Vps291;nSyb-GAL4/+; (2, grey) Vps291;nSyb-GAL4/UAS-dVps29; (3, blue) Vps291;nSyb-GAL4/UAS-dTBC1D5. (E) Pan-neuronal overexpression of dTBC1D5 (nsyb>dTBC1D5) rescues synaptic transmission in Vps291 mutants. Quantification of ERG on-transients (n = 8) from adults raised using a 12 hr light/dark cycle. (F, G) The Vps29L152E mutation, predicted to disrupt the Vps29-TBC1D5 interaction, fails to complement Vps291, causing impaired synaptic transmission (F) and locomotor impairment (G). Quantification of ERG on-transients in 30-day-old flies raised in complete darkness (F) (n = 12–14) or locomotor behavior in 20-day-old flies (G) (n = 5–6 groups). See also Figure 5—figure supplement 1A. (H) The Vps29L152E mutation causes increased expression of Vps29 (anti-GFP, green) and Rab7 (anti-Rab7, red). Whole-mount brain immunofluorescence shown for Vps29L152E.GFP or Vps29WT.GFP homozygotes (2-day-old adults). Scale bars, 100 µm. See also Figure 5—figure supplement 1B. Statistical analysis based on Student’s t-test (A, F, G) or one-way ANOVA (B–E). All error bars denote SEM. n.s., not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Figure 5—figure supplement 1. Additional characterization of the Vps29L152E.
Loss of Vps29 causes lysosomal dysfunction during aging
As introduced above, retromer mediates the recycling of protein cargoes from the endolysosomal system to the trans-Golgi network or plasma membrane. Moreover, retromer loss may impair lysosomal biogenesis and function, for example by disrupting delivery of key hydrolases (Maruzs et al., 2015). In the Drosophila retina, besides aberrant trafficking of Rh1 (Wang et al., 2014), loss of Vps35 causes accumulation of ceramide lipid species (Lin et al., 2018), which contributes to lysosomal expansion, cellular stress, and ultimately photoreceptor loss. We confirmed that glucosylceramide similarly accumulates in Vps291 homozygous photoreceptors (Figure 6A), consistent with the retinal degeneration phenotype. In order to better understand the proximal consequences of retromer mislocalization that lead to neuronal dysfunction, we performed a series of experiments to assay lysosomal function in the adult brains of Vps29 mutants. We first examined the lysosomal proteases, cathepsin D (CTSD) and cathepsin L (CTSL). These enzymes are each synthesized as propeptides in the endoplasmic reticulum (ER) and become active following cleavage in the acidic, lysosomal milieu. Lysosomal dysfunction therefore commonly leads to reduced levels of mature cathepsins and increased levels of the immature proforms (Hasanagic et al., 2015; Li et al., 2017). We detected normal levels of mature CTSL and increased mature CTSD in adult head homogenates from 1-day-old Vps291/Df animals (Figure 6B and Figure 6—figure supplement 1A). However, in 30-day-old animals, we found that the uncleaved proforms of both cathepsins were sharply increased, consistent with progressive lysosomal dysfunction with aging.
Figure 6. Loss of Vps29 causes age-dependent, progressive lysosomal dysfunction in the brain.
(A) In the absence of Vps29, glucosylceramide (anti-GlcCer, green) accumulates in the retina. Tissue is counterstained for actin (phalloidin, red) to highlight the photoreceptor rhabdomeres. Glucosylceramide signal was quantified from a 36.94 × 36.94 µm2 region encompassing ~10 ommatidia in 30-day-old animals (n = 10) raised in dark conditions, including GMR-w-RNAi/+; Vps291; GR/+ (controls) and GMR-w-RNAi/+; Vps291. Eye pigment was removed using RNAi against the w gene to reduce auto-fluorescence. A representative ommatidium (boxed) is shown at higher-power (right). Scale bars, 5 µm. (B) The uncleaved, CTSL proform is increased in aged animals lacking Vps29, consistent with diminished lysosomal proteolytic capacity. Western blots from adult fly head homogenates were probed for CTSL and Tubulin (loading control), and quantified based on n = 3 replicate experiments. See also Figure 6—figure supplement 1A. (C) Autophagic flux is reduced in aged animals lacking Vps29, and this phenotype is suppressed by reduction of Rab7. Western blots of adult head homogenates were probed for autophagic markers, including p62, Atg8, polyubiquitin (FK1), or Tubulin (loading control), and quantified based on n = 8 replicate experiments. See also Figure 6—figure supplement 1B,C. Statistical analysis based on Student’s t-test (A, B) and one-way ANOVA (C). All error bars denote SEM. n.s., not significant; *, p<0.05; **, p<0.01.
Figure 6—figure supplement 1. Additional studies of lysosomal proteolysis and autophagy.
We next examined well-established markers of lysosomal autophagy, which plays a critical role in nervous system homeostasis and neurodegeneration (Martini-Stoica et al., 2016; Menzies et al., 2015). Substrate degradation is triggered when Atg8-decorated autophagosomes fuse with lysosomes, leading to turnover of Ref(2)P/p62 and concomitant clearance of polyubiquitinated proteins. We did not observe any accumulation of these markers in heads from either 1- or 30-day-old Vps291/Df flies (Figure 6—figure supplement 1B,C), consistent with preserved autophagic flux. Interestingly, however, at more extreme ages (45 days), Vps29 mutants showed evidence of accelerated autophagic failure, with more significant elevation of both p62 and Atg8, and accumulation of polyubiquitinated proteins (Figure 6C). Notably, reduction of Rab7 (Rab7Gal4-KO/+) improved autophagic clearance in Vps29 mutant brains.
Lastly, in order to directly visualize lysosomal ultrastructure, we performed transmission electron microscopy (TEM) on retinae and brains from 30-day-old Vps291/Df animals (Figure 7 and Figure 7—figure supplement 1). For the retinal studies, we selected conditions for which photoreceptor depolarization is preserved, preceding overt retinal neurodegenerative changes. Indeed, retinal TEM revealed normal numbers and morphology of photoreceptors; however, we documented significantly increased numbers of lysosomes, multivesicular bodies, and autophagic vacuoles. Further, lysosomes were frequently aberrantly enlarged and filled with granular, electron-dense material. These findings are highly suggestive of endolysosomal dysfunction in Vps291/Df animals, in agreement with results from other assays. Interestingly, although synaptic transmission is disrupted in these animals (i.e. reduced ERG on/off transients), Vps29 mutant synaptic terminals in the lamina appeared unremarkable. We observed normal synapse numbers and size, nor did we detect any other apparent evidence of synaptic degeneration. Lastly, we examined TEM of adult brain sections in 30-day-old animals, focusing on cortical regions with densely packed neuronal cell bodies in the dorsal-posterior brain. Consistent with findings in the retina, we discovered significantly increased numbers of aberrant lysosomal structures (multilamellar bodies) in Vps29 mutants. Collectively, our data indicate that retromer dysfunction following loss of Vps29 is associated with progressive lysosomal structural and functional degeneration in the aging nervous system.
Figure 7. Loss of Vps29 disrupts lysosomal ultrastructure in the brain.
(A) Transmission electron microscopy (TEM) reveals overall preserved photoreceptor morphology, but aberrant endolysosomal structures in retinae from 30-day-old animals lacking Vps29. Within each ommatidium (yellow outline), the percentage of photoreceptors (PR) with endolysosomal defects was quantified. Asterisks denote photoreceptors with aberrant endolysosomal structures. Quantification based on n = 30 ommatidia from three animals per genotype. See also Figure 7—figure supplement 1A,B. (B) At higher magnification, TEM reveals an increase in lysosomes, multivesicular bodies, autophagic vacuoles, and multilamellar bodies in Vps29 mutant retinae. Lysosomes were frequently observed to be aberrantly enlarged and filled with granular, electron-dense material. (C) Distinct endolysosomal structures and/or compartments were quantified in n = 15 photoreceptors, including five photoreceptors from three animals for each genotype. (D) Increased numbers of multi-lamellar bodies (asterisks) are observed in cortical neurons from brains 30-day-old animals lacking Vps29. Neuronal nuclei (‘N’) are outlined. Quantification based on cell counts from n = 4 animals (50 cells per brain). See also Figure 7—figure supplement 1D. Statistical analysis (A, C, D) based on Student’s t-test. All error bars denote SEM. *, p<0.05; **, p<0.01; ***, p<0.001.
Figure 7—figure supplement 1. Additional ultrastructural analysis of Vps29 mutants.
Discussion
Although strongly implicated in pathogenesis of human neurodegenerative disease, the requirements for retromer in the aging brain remain poorly defined. Our discovery that Vps29 is dispensable for Drosophila embryogenesis provides an unexpected opportunity to examine the neuronal consequences of retromer dysfunction in vivo. In the absence of Vps29, we document age-dependent impairment in lysosomal proteolysis and autophagy, leading to apparent accumulation of undigested substrates and expansion of the endolysosomal compartment. These cellular changes are accompanied by progressive nervous system dysfunction, with synaptic transmission especially vulnerable. Unexpectedly, Vps29 loss did not affect the expression or stability of other retromer components but influenced their localization via a Rab7- and TBC1D5-dependent regulatory pathway.
VPS29 is required for retromer recruitment via Rab7 and TBC1D5
The retromer core initiates cargo recognition and mediates the engagement of other factors that enable proper endocytic trafficking (Cullen and Steinberg, 2018). However, the differential requirements of each protein within the heterotrimer, including VPS35, VPS26, and VPS29, remain incompletely defined. Structural studies suggest the retromer core has an elongated, flexible structure, with VPS35 serving as a central scaffold, binding VPS26 at its N‐terminus, and VPS29 at its C‐terminus (Hierro et al., 2007; Kovtun et al., 2018; Lucas et al., 2016). Consistent with this, loss of VPS35 destabilizes the retromer complex, resulting in reduced VPS26 and VPS29 protein, and this result has been confirmed both in vitro and in vivo (Cui et al., 2019; Liu et al., 2014; Wang et al., 2014). Similarly, knockdown or knockout of VPS29 in mammalian epithelial cell culture compromises retromer stability, causing loss of the other components (Fuse et al., 2015; Jimenez-Orgaz et al., 2018). Surprisingly, in the absence of Vps29 in Drosophila, we found that Vps35 and Vps26 are present at normal levels and remain tightly associated. Instead, Vps35 appears to be mislocalized, shifting from neuropil to soma in the adult brain, and likely disrupting its normal function. Loss of Vps29 also causes apparent hyperactivation (and mislocalization) of Rab7, and a mutation previously shown to disrupt the VPS29-TBC1D5 interaction shows similar phenotypes. Importantly, reduction of Rab7 or overexpression of TBC1D5 potently suppresses Vps29 loss-of-function. In the adult brain, perinuclear accumulation of Vps35/Rab7 strongly suggests aberrant localization to the late endosome and lysosome, based on the overlap with Arl8 and Spinster. Our in vivo findings recapitulate a two-step molecular mechanism for retromer recruitment and release in neurons (Figure 8). First, the retromer core is recruited to the endosomal membrane by Rab7-GTP, allowing it to participate in cargo recycling. Subsequently, Vps29 engages TBC1D5, which activates GTP hydrolysis of Rab7, thereby releasing retromer from the endosome. We propose that in the absence of Vps29, retromer is trapped at the endosome membrane in the neuronal cell body, leading to sequestration of functional complexes, and progressive impairment in endocytic trafficking.
Figure 8. Model for Vps29-dependent retromer recruitment and release.
In neurons, the retromer core Vp26-Vps35-Vps29 is recruited by Rab7 to the endosomal membrane. Vps29 engages TBC1D5, which promotes inactivation of Rab7 and release of Vps35. In the absence of Vps29, the residual retromer complex is trapped at the endosomal membrane.
The reciprocal interplay and interdependence of retromer and Rab7 that we document in the Drosophila nervous system is consistent with prior studies in cell culture (Jimenez-Orgaz et al., 2018; Liu et al., 2012; Seaman et al., 2009). By contrast, the viability of Vps29 mutants as well as our finding of a more selective, regulatory role for Vps29 in complex localization is unexpected. Unlike the other retromer core subunits, Vps29 is dispensable for embryogenesis and loss-of-function causes milder retinal phenotypes than Vps35 or Vps26. Moreover, Vps35 overexpression partially rescued selected Vps29 phenotypes, consistent with a context-dependent, regulatory role. Since Vps35 can weakly bind TBC1D5 (Jia et al., 2016), it may be capable of inactivating Rab7, compensating in part for the absence of Vps29. Our finding that retromer retains some residual activity in flies lacking Vps29 is reminiscent of results from C. elegans (Lorenowicz et al., 2014). Moreover, in S. cerevisiase, interaction of Vps26 and Vps35 are similarly preserved following loss of Vps29 (Reddy and Seaman, 2001). Importantly, these data suggest that the specific requirement(s) for Vps29—and by extension, retromer activity—may be context dependent, varying with cell-type (e.g. neuron) and/or specific cargo (e.g. Rh1, ceramides, or others). While Vps29 mutants altered Vps35 subcellular localization in both the adult and larval brains causing relative loss from neuropil regions, potential differences were also noted: the apparent redistribution to soma was only seen in adults. It is also possible that tissue- or species-specific differences might relate to Vps29 participation in other endosomal sorting machinery besides retromer, such as the recently described ‘retriever’ (McNally et al., 2017); however, this complex has not yet been studied in Drosophila. Although we have found that human VPS29 is capable of functional substitution in flies, it will be important to determine whether our findings also apply in the mammalian nervous system context.
The retromer and endolysosomal trafficking in neurons
Our characterization of flies lacking Vps29 points to important roles for retromer in both lysosomal and synaptic homeostasis in neurons, interdependent processes that similarly require proper endocytic trafficking. Following Vps29 loss-of-function, we detected evidence of progressive deterioration in lysosomal function in the adult brain, based on markers of cathepsin maturation and autophagic flux. In both cases, lysosomal function was preserved in newly eclosed animals, but deficits emerged gradually with aging. This result suggests that neurons can initially compensate for retromer insufficiency, whereas adaptive mechanisms may breakdown during aging. Vps35 was strongly mislocalized in 1-day-old animals, suggesting that the manifestation of age-dependent vulnerability likely involves more downstream consequences of retromer dysfunction, such as the accumulation of undigested substrates and resulting lysosomal expansion. Indeed, we found ultrastructural evidence of lysosomal stress in the aged retina and brain, including significantly enlarged lysosomes that were filled with electron-dense and/or multilammellar material. One caveat for interpretation is that TEM data was not included for newly eclosed animals. Nevertheless, our results are consistent with evidence from other experimental systems, that protein and lipid cargoes accumulate gradually in the late endosome and lysosomes in the absence of retromer activity (Lin et al., 2018; Tang et al., 2015a; Wang et al., 2014; Wen et al., 2011). Neuronal compensation may entail increasing capacity for substrate turnover, since we found that mature forms of CTSD and markers of autophagic flux were increased in young animals (Figure 6—figure supplement 1). It is also possible that the production of critical membrane proteins dependent on retromer for recycling can be boosted, at least temporarily. The initial resilience of the brain to Vps29 deficiency that we uncover in Drosophila is consistent with relative preservation of autophagy following VPS29 knockout in HeLa cells (Jimenez-Orgaz et al., 2018). However, there is ample evidence from animal model studies that aging is accompanied by reduced degradative capacity in neurons, which may ultimately contribute to decompensation and increased proteotoxic stress (Mattson and Magnus, 2006).
We additionally found that Vps29 is required for synaptic transmission in both the Drosophila retina and larval NMJ, producing a phenotype characteristic of other genes that regulate endocytosis and synaptic vesicle recycling (Bellen et al., 2010; Harris and Littleton, 2015). In Drosophila S2 cells, Vps35 has been shown to participate in endocytosis (Korolchuk et al., 2007), and our findings confirm and extend prior work (Inoshita et al., 2017) implicating Vps35 in synaptic structure and function at the NMJ. Whereas both genes appear similarly required for synaptic vesicle endocytosis, loss of Vps35 but not Vps29, also affected spontaneous NMJ activity, causing increased miniature excitatory junction potentials (Inoshita et al., 2017). This is consistent with our other data suggesting Vps29 causes overall milder defects. Vps29 synaptic phenotypes were suppressed by either reduction of Rab7 or overexpression of TBC1D5, similar to our studies of lysosomal phenotypes. Interestingly, ERGs also revealed age-dependent, progressive decline in synaptic transmission. Despite evidence of significant degradation of synaptic function with aging, TEM studies of the Drosophila lamina did not reveal overt synaptic structural changes, suggesting a more subtle, predominantly functional defect. Since retromer is present throughout embryonic and larval development, we cannot exclude the possibility of developmental defects due to Vps29 loss-of-function. Indeed, Vps35 was mislocalized in the Vps29 mutant larval brain and we documented increased numbers of NMJ synaptic boutons. Nevertheless, the adult brain appeared grossly normal, and electroretinograms and climbing were unaffected in newly eclosed flies.
In sum, we consider two non-exclusive models for potential retromer requirement(s) at the synapse. First, retromer may regulate the trafficking of a key factor required for synaptic membrane endocytosis and/or replenishing of the vesicle pool from synaptic endosomes. Second, Vps29-related synaptic dysfunction may instead be related, more broadly, to progressive lysosomal dysfunction. In fact, recent studies have linked synaptic endosomes, lysosomes, and autophagosomes to presynaptic proteostasis, including during vesicle recycling and release (Jin et al., 2018; Wang et al., 2017). For example, another Rab GTPase activating protein, TBC1D24—Skywalker in Drosophila—has been shown to regulate synaptic vesicle recycling and quality control via a sorting endosome at NMJ terminals (Fernandes et al., 2014; Uytterhoeven et al., 2011). Interestingly, in the Drosophila visual system, we found that raising Vps29 or Vps35 mutants in the dark rescued retinal degeneration but not synaptic transmission defects, consistent with an uncoupling of retromer requirements in these two spatially distinct processes. Thus, it is possible—if not likely—that synaptic endolysosomal trafficking and function can be regulated independently from that of the neuronal soma.
Additional studies will be required to further dissect and refine our understanding of retromer-dependent synaptic mechanisms. For example, it may be informative to perform neurophysiology studies in mutants for other genes encoding retromer partners (e.g. TBC1D5) or regulators of late endosome-lysosome fusion, such as components of the HOPS complex (Fernandes et al., 2014; Lund et al., 2018). It will also be important to examine synaptic physiology following retromer loss in the mammalian brain. Retromer components are present at synaptic terminals in mouse primary neuronal culture (Munsie et al., 2015; Vazquez-Sanchez et al., 2018) and in cortical synaptosome preparations (Tsika et al., 2014). However, functional studies to date have largely focused on the post-synaptic membrane, where evidence supports retromer requirements for trafficking of glutamatergic and adrenergic neurotransmitter receptors (Choy et al., 2014; Tian et al., 2015).
Retromer and neurodegenerative disease
Retromer dysfunction has been linked to pathogenesis of Parkinson’s and Alzheimer’s disease (Small and Petsko, 2015). In both neurodegenerative disorders, synaptic dysfunction is an early pathologic feature, and lysosomal autophagy is also strongly implicated (Ihara et al., 2012; Wang et al., 2017). Our findings of age-dependent, progressive synaptic and lysosomal dysfunction in the adult brain of Drosophila lacking Vps29 may therefore be relevant for our understanding of retromer in human diseases. In fact, variants at numerous other genetic loci related to endocytic trafficking and synaptic maintenance have been discovered as risk factors for Alzheimer’s disease (BIN1, PICALM, CD2AP, SORL1) (Karch et al., 2014) and Parkinson’s disease (SNCA, LRRK2, SH3GL2/EndoA, RAB7L1) (Soukup et al., 2018). Genetic links have also recently emerged between Parkinson’s disease and lysosomal storage disorders, comprising a heterogeneous group of recessive disorders arising from defects in lysosomal biogenesis and/or function (Ysselstein et al., 2019). These disorders, which can include neurodegenerative features, are characterized by the accumulation of undigested substrates and lysosomal expansion (e.g. glucosylceramide in Gaucher’s disease). Importantly, retromer participates in the trafficking of lysosomal hydrolases (Cui et al., 2019; Seaman et al., 1997), and in the absence of Vps29, we documented accumulation of glucosylceramides along with ultrastructural evidence of brain lysosomal pathology similar to lysosomal storage disorders. Based on mouse models, synaptic dysfunction may be an early manifestation in lysosomal storage disorders similar to Vps29 mutant flies (Mitter et al., 2003; Ohara et al., 2004; Sambri et al., 2017). Aberrant lysosomal morphology has also been described in both Alzheimer’s and Parkinson’s disease models (Giasson et al., 2002; Stokin et al., 2005) and in human postmortem brain (García-Sanz et al., 2018; Piras et al., 2016). Targeting the retromer for therapeutic manipulation in neurodegenerative disease is one promising approach, given the availability of small molecule chaperones that bind Vps29 (Mecozzi et al., 2014; Vagnozzi et al., 2019; Young et al., 2018). However, since the endolysosomal system has many functions, including within neurons and other cell types, it will be essential to pinpoint the specific retromer mechanism(s) responsible for age-related brain diseases.
Materials and methods
Key resources table.
| Reagent type (species) or resource |
Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Gene (D. melanogaster) | Vps35 | FLYB: FBgn0034708 | ||
| Gene (D. melanogaster) | Vps29 | FLYB: FBgn0031310 | ||
| Gene (D. melanogaster) | Vps26 | FLYB: FBgn0014411 | ||
| Gene (D. melanogaster) | TBC1D5 | FLYB: FBgn0038129 | ||
| Gene (D. melanogaster) | Rab7 | FLYB: FBgn0015795 | ||
| Genetic reagent (D. melanogaster) | FRT40A | Bloomington Drosophila Stock Center | FLYB: FBti000207; RRID:BDSC_1816 | y1 w1118; P{neoFRT}40A |
| Genetic reagent (D. melanogaster) | ey-FLP; FRT40A | Bloomington Drosophila Stock Center | FLYB: FBti0015982; RRID:BDSC_5622 | yd2, w1118, ey-FLP,GMR-lacZ;P{neoFRT}40A,w+,cl/CyO,y+ |
| Genetic reagent (D. melanogaster) | ey3.5-FLP; FRT40A | PMID:15848801 | y w ey3.5-FLP; FRT40A,cl, w+/CyO, Kr > GFP | |
| Genetic reagent (D. melanogaster) | nSyb-Gal4 | Bloomington Drosophila Stock Center | FLYB: FBti0150361; RRID:BDSC_51635 | y1 w*; P{nSyb-GAL4.S}3 |
| Genetic reagent (D. melanogaster) | nos-Cas9 | Bloomington Drosophila Stock Center | FLYB: FBti0159183; RRID:BDSC_54591 | y1, w*,M{nos-Cas9.P}ZH-2A |
| Genetic reagent (D. melanogaster) | Vps35MH20/CyO | Bloomington Drosophila Stock Center | FLYB: FBal0221635; RRID:BDSC_67202 | w; P{neoFRT}42D,Vps35MH20/CyO, Kr > GFP |
| Genetic reagent (D. melanogaster) | Df | Bloomington Drosophila Stock Center | FLYB: FBti0073468; RRID:BDSC_7491 | Df(2L)Exel6004 |
| Genetic reagent (D. melanogaster) | UAS-deGradFP | Bloomington Drosophila Stock Center | FLYB: FBti0147362; RRID:BDSC_38421 | w*; P{w[+mC]=UAS-Nslmb-vhhGFP4}3 |
| Genetic reagent (D. melanogaster) | GMR-w-RNAi | Bloomington Drosophila Stock Center | FLYB: FBti0074622; RRID:BDSC_32067 | GMR-w-RNAi13D |
| Genetic reagent (D. melanogaster) | UAS-Spin-GFP | Bloomington Drosophila Stock Center | FLYB:FBti0148827 RRID:BDSC_39668 |
w*; P{UAS-spin.myc-EGFP} |
| Genetic reagent (D. melanogaster) | Vps35GFP | This study | Progenitor = w; Vps35TagRFP-T; TagRFP-T cassette was replaced by EGFP | |
| Genetic reagent (D. melanogaster) | Vps35RFP | PMID:26700726 | w; Vps35TagRFP-T | |
| Genetic reagent (D. melanogaster) | eyFLP;FRT42D | PMID:24781186 | y w,eyFLP,GMR-lacZ; P{neoFRT}42D,w+,cl/CyO,Kr > GFP | |
| Genetic reagent (D. melanogaster) | UAS-Vps35 | PMID:24781186 | y w; PBac{UAS-Vps35-HA} | |
| Genetic reagent (D. melanogaster) | Rab7EYFP | Bloomington Drosophila Stock Center | FLYB: FBst0062545 RRID:BDSC_62545 |
w1118; TI{TI}Rab7EYFP |
| Genetic reagent (D. melanogaster) | Rab7Gal4-KO/TM3,Sb | PMID:24327558 | FLYB: FBal0294205 | FRT82B, Rab7Gal4-KO/TM3,Sb |
| Genetic reagent (D. melanogaster) | UAS-Venus-Rab7Q67L/CyO | PMID:24327558 | FLYB: FBal0294206 | PBac{UAS-Rab7.Q67L.Venus} |
| Genetic reagent (D. melanogaster) | UAS-Venus-Rab7T22N/CyO | PMID:24327558 | FLYB: FBal0294207 | PBac{UAS-Rab7.T22N.Venus} |
| Genetic reagent (D. melanogaster) | UAS-Venus-Rab7WT/CyO | PMID:24327558 | FLYB: FBal0294208 | PBac{UAS-Rab7.WT.Venus} |
| Genetic reagent (D. melanogaster) | Vps291/CyO,twi-GFP | This study | fly strain carrying the ywing2+ dominant marker replacing the gene Vps29 | |
| Genetic reagent (D. melanogaster) | Vps29WT.GFP/CyO,ubi-GFP | This study | fly strain carrying the Vps29 gene with EGFP…(GGS)4 sequence inserted at the N-terminus of Vps29 | |
| Genetic reagent (D. melanogaster) | Vps29L152E.GFP/CyO,ubi-GFP | This study | fly strain carrying the Vps29 gene with EGFP…(GGS)4 sequence inserted at the N-terminus of Vps29. L152 amino acid is mutated to E | |
| Genetic reagent (D. melanogaster) | Vps29-GR | This study | CH322-128G03 (FLYB: FBcl0761727) | |
| Genetic reagent (D. melanogaster) | UAS-dVps29 | This study | y w; PBac{UAS-dVps29-myc} | |
| Genetic reagent (D. melanogaster) | UAS-hVps29-1 | This study | y w; PBac{UAS-hVps29-1-FLAG} | |
| Genetic reagent (D. melanogaster) | UAS-hVps29-2 | This study | y w; PBac{UAS-hVps29-2-FLAG} | |
| Genetic reagent (D. melanogaster) | UAS-hVps29-3 | This study | y w; PBac{UAS-hVps29-3-FLAG} | |
| Genetic reagent (D. melanogaster) | UAS-dTBC1D5 | This study | y w; PBac{UAS-dTBC1D5-myc} | |
| Genetic reagent (D. melanogaster) | w; FRT40A, Vps291/CyO | This study | Recombinant betweenFRT40A and Vps291 | |
| Genetic reagent (D. melanogaster) | w;Vps291,Vps35GFP/CyO | This study | Recombinant betweenVps35GFP and Vps291 | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO; Vps29-GR/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO; Rab7EYFP/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO; nSyb-Gal4/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO; UAS-dVps29/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO; UAS-hVps29/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO;UAS-dTBC1D5/TM6B | This study | Derived by crosses | |
| Genetic reagent (D. melanogaster) | w;Vps291/CyO;UAS-dVps35/TM6B | This study | Derived by crosses | |
| Antibody | FITC-conjugated anti-GFP (mouse monoclonal) | Santa Cruz Biotechnology | Cat# sc-9996 FITC; RRID:AB_627695 | 1:100 for IF |
| Antibody | Anti-Rab7 (mouse monoclonal) | Developmental Studies Hybridoma Bank | RRID:AB_2722471 | 1:100 for IF; 1:1000 for WB |
| Antibody | Anti-Elav (Rat monoclonal) | Developmental Studies Hybridoma Bank | DSHB: Elav-7E8A10; RRID:AB_528218 | 1:500 for IF |
| Antibody | Anti-tubulin Clone DM1A (mouse monoclonal) | Sigma Aldrich | Cat# T6199; RRID:AB_477583 | 1:1000 for WB |
| Antibody | Anti-Vps29 (goat polyclonal) | LifeSpan Biosciences | Cat# LS-C55674; RRID:AB_2214913 | 1:2000 for WB |
| Antibody | Anti-Vps35 (Guinea pig polyclonal) | This study | against C-terminal 338 amino acids of fly Vps35; 1:2000 for WB | |
| Antibody | Anti-Vps26 (Guinea pig polyclonal) | PMID:24781186 | 1:2000 for WB 1:500 for IF |
|
| Antibody | Anti-CTSL (mouse monoclonal) | R and D Systems | Cat# MAB22591; RRID:AB_2087830 | 1:1000 for WB |
| Antibody | Anti-CTSD (goat polyclonal) | Santa Cruz Biotechnology | Cat# sc-6487; RRID:AB_637895 | 1: 500 for WB |
| Antibody | Rabbit anti-Atg8 | PMID:27068460 | 1:1000 for WB | |
| Antibody | Anti-Polyubiquitinylated conjugates Clone FK1 (mouse monoclonal) | Enzo Life Sciences | Cat# BML-PW8805-0500; RRID:AB_2052280 | 1:1000 for WB |
| Antibody | Rabbit anti-p62/Ref(2)p | PMID:25686248 | 1:2000 for WB | |
| Antibody | Rabbit anti-Arl8 | Developmental Studies Hybridoma Bank | DSHB Cat# Arl8, RRID:AB_2618258 | 1:1000 for IF |
| Antibody | Anti-actin clone C4 (mouse monoclonal) | Millipore | Cat# MAB1501; RRID:AB_2223041 | 1:1000 for WB |
| Antibody | Cy3-conjugated anti-HRP | Jackson ImmunoResearch | Cat# 123-165-021; RRID:AB_2338959 | 1:150 for IF |
| Antibody | Cy3-conjugated Goat anti-mouse IgG | Jackson ImmunoResearch | Cat# 115-165-146; RRID:AB_2338690 | 1:500 for IF |
| Antibody | Cy3-conjugated Goat anti-Rat IgG | Jackson ImmunoResearch | Cat# 112-165-003; RRID:AB_2338240 | 1:500 for IF |
| Antibody | Mouse anti-goat IgG-HRP | Santa Cruz Biotechnology | Cat# sc-2354, RRID:AB_628490 | 1:5000 for WB |
| Antibody | Goat anti-mouse IgG-HRP | Santa Cruz Biotechnology | Cat# sc-2005; RRID:AB_631736 | 1:5000 for WB |
| Antibody | Goat anti-rabbit IgG-HRP | Santa Cruz Biotechnology | Cat# sc-2004; RRID:AB_631746 | 1:5000 for WB |
| Antibody | Rabbit anti-Glc-Cer | Glycobiotech | Cat# RAS_0010 | 1:250 for IF |
| Recombinant DNA reagent | Plasmid: pUASTattb_dVps29-myc | This study | Progenitors: GH25884 (cDNA) | |
| Recombinant DNA reagent | Plasmid: pUASTattb_dTBC1D5-myc | This study | Progenitors: BS16827 (cDNA) | |
| Recombinant DNA reagent | Plasmid: pUASTattb_hVps29-1-FLAG | This study | Progenitors: OHu00442D (cDNA) | |
| Recombinant DNA reagent | Plasmid: pUASTattb_hVps29-2-FLAG | This study | Progenitors: OHu02289D (cDNA) | |
| Recombinant DNA reagent | Plasmid: pUASTattb_hVps29-3-FLAG | This study | Progenitors: OHu05688D (cDNA) | |
| Commercial assay or kit | Subcloning Efficiency DH5α competent cells | Thermo Fisher Scientific | Cat# 18265017 | |
| Commercial assay or kit | Q5 Site-Directed Mutagenesis Kit | NEB | Cat# E0554S | |
| Commercial assay or kit | NEBuilder HiFi DNA Assembly Cloning Kit | NEB | Cat# E5520S | |
| Commercial assay or kit | PureLink Genomic DNA Kits | Thermo Fisher Scientific | Cat# K182001 | |
| Commercial assay or kit | GFP-Trap agarose beads | Allele Biotechnology | Cat# ABP-NAB-GFPA100 | |
| Chemical compound, drug | 2X Laemmli Sample Buffer | Bio-Rad | Cat# 161–0737 | |
| Chemical compound, drug | 4% paraformaldehyde in 1XPBS | ChemCruz | Cat# sc-281692 | |
| Chemical compound, drug | RapiClear | SunJin Lab Co. | ||
| Chemical compound, drug | Vectashield | Vector Laboratories | Cat# H-1000 | |
| Chemical compound, drug | Protein A/G agarose | Thermo Fisher | Cat# 20421 | |
| Chemical compound, drug | 8% glutaraldehyde | EMS | Cat# 16020 | |
| Chemical compound, drug | Cacodylic Acid, Trihydrate Sodium 100 g | EMS | Cat# 12300 | |
| Chemical compound, drug | EM-grade glutaraldehyde, 25% Aq solution | EMS | Cat# 16221 | |
| Chemical compound, drug | Osmium tetroxide4% Aq solution | EMS | Cat# 19191 | |
| Chemical compound, drug | Paraformaldehyde 16% Aq Solution | EMS | Cat# 15711 | |
| Chemical compound, drug | Propylene Oxide | EMS | Cat# 20411 | |
| Chemical compound, drug | Koptec 200 Proof100% ethanol Anhydrous | VWR | Cat# 89125–186 | |
| Chemical compound, drug | Embed-812 | EMS | Cat# 14901 | |
| Chemical compound, drug | NMA | EMS | Cat# 19001 | |
| Chemical compound, drug | DDSA | EMS | Cat# 13711 | |
| Chemical compound, drug | DMP-30 | EMS | Cat# 13600 | |
| Chemical compound, drug | Uranyl Acetate | EMS | Cat# RT22400 | |
| Chemical compound, drug | Lead Nitrate | EMS | Cat# RT17900-25 | |
| Chemical compound, drug | Phalloidin 488 nm | ThermoFisher | Cat# AB_2315147 | |
| Chemical compound, drug | FM 1-43FX | Invitrogen | Cat# F35355 | |
| Chemical compound, drug | Western Lightning Plus-ECL | PerkinElmer | Cat# 121001EA | |
| Software, algorithm | Leica Application Suite X | Leica | RRID:SCR_013673 | |
| Software, algorithm | LabChart Reader | ADInstruments | https://www.adinstruments.com/products/labchart-reader | |
| Software, algorithm | ImageJ | National Institute of Health | RRID:SCR_003073 | |
| Sequence-based reagent | dVps29-myc-F | This study | 5’-GAAGATCTTCATGCTCGTTCTGGTACTCGGCGA-3’ | |
| Sequence-based reagent | dVps29-myc-R | This study | 5’-GCTCTAGACTACAGATCCTCTTCTGAGATGAGTTTTTGTTCGATCTTCTTGTACTCGATGCGCTCCA-3’ | |
| Sequence-based reagent | dTBC1D5-myc-F | This study | 5’-GAAGATCTATCAACATGACTGTTTGGGGAATAGAAGCCATCA-3’ | |
| Sequence-based reagent | dTBC1D5-myc- R | This study | 5’-GCTCTAGATCACAGATCCTCTTCTGAGATGAGTTTTTGTTCACTCGATTCGTTTCGATGCCGT-3’ | |
| Sequence-based reagent | hVps29-1-F | This study | 5’-CCGCCTCGAGGCCACCATGTTGGTGTTGGT-3’ | |
| Sequence-based reagent | hVps29-2-F | This study | 5’-CCGCCTCGAGGCCACCATGGCTGGGCACA-3’ | |
| Sequence-based reagent | hVps29-3-F | This study | 5’-CCGCCTCGAGGCCACCATGAGCAGGTGTGCT-3’ | |
| Sequence-based reagent | hVps29-R | This study | 5’-CTAGTCTAGATTATCACTTATCGTCGTCATCCTTGTAATCAGGT-3’ | |
| Sequence-based reagent | Vps29-P1-F | This study | 5’-GAACCTGACGTATCCGGAGC-3’ | |
| Sequence-based reagent | Vps29-P1-R | This study | 5’-TCGCCGATCAGTTGGTACAC-3’ | |
| Sequence-based reagent | Vps29-P2-F | This study | 5’-CTCGTTCTGGTACTCGGCG-3’ | |
| Sequence-based reagent | Vps29-P2-R | This study | 5’-ACGAACGAAGGCACCACATT-3’ | |
| Sequence-based reagent | Vps29-P3-F | This study | 5’-GGCCGCATACATCACATCCT-3’ | |
| Sequence-based reagent | Vps29-P3-R | This study | 5’-GAATTTGTTGCCGTGCTCGT-3’ | |
| Sequence-based reagent | Vps35-F (Internal control) | This study | 5’-TTGTACCTCCTCATAACAGTGGG-3’ | |
| Sequence-based reagent | Vps35-R (Internal control) | This study | 5’-TCGTTCTCCTCAACCATCACAT-3’ | |
| Other | Leica SP8 confocal microscope | Leica | ||
| Other | Leica DM 6000 B system | Leica | ||
| Other | Zeiss LSM 880 with Airyscan | Zeiss |
Fly stocks and husbandry
A complete list of fly strains used in this study is included in the Key Resources Table. Detailed information on experimental genotypes can also be found in figures and figure legends. The Vps291 null allele was generated using CRISPR/Cas9-mediated gene replacement, as previously described (Li-Kroeger et al., 2018). Briefly, a dominant marker ywing2+ flanked by homology arms on each side, along with sgRNA expression plasmids, were injected into embryos expressing Cas9 (y1,w*,M{nos-Cas9.P}ZH-2A). G0 animals were next crossed to y w, and progeny were screened for the presence of the yellow+ wing marker to identify Vps291 (Vps29ywing2+). Studies of Vps29 mutant flies used either Vps291 homozygotes or the transheterozygous genotype, Vps291/Df(2L)Exel6004 (referred to as Vps291/Df). To generate the Vps29 genomic rescue strain, a 23 kb P[acman] genomic fragment (CH322-128G03) including the Vps29 locus was injected into y,w,ΦC31; VK33 attP embryos, followed by selection of F1 transformants. All studies using the transgenic Vps29 BAC examined the genomic rescue construct (GR) in heterozygosity (either Vps291;GR/+ or Vps291/Df;GR/+).
In order to generate the Vps29WT.GFP and Vps29L152E.GFP alleles, we again used the CRISPR/Cas9 gene-replacement system, starting with the Vps291 strain. The GFP coding sequence was cloned in-frame and proximal to the Vps29 cDNA using NEBuilder HiFi DNA Assembly Cloning Kit (NEB). Using Q5 Site-Directed Mutagenesis Kit (NEB), the L152E mutation was introduced to the GFP::Vps29 plasmid. As above, the GFP::Vps29 or GFP::Vps29L152E constructs were each injected into y1 M{nos-Cas9.P}ZH-2A w*; Vps291/CyO flies. G0 flies were crossed to y w, and F1 progeny were screened for loss of the yellow+ marker to establish the Vps29WT.GFP and Vps29L152E.GFP strains. The sequence of all CRISPR/Cas9-generated strains were confirmed by genomic PCR followed by Sanger sequencing. Genomic DNA from a single fly was prepared using ‘squish buffer’ (10 mM Tris-Cl pH 8.0, 1 mM EDTA, 25 mM NaCl, and 0.2 mg/ml Proteinase K). Total genomic DNA was extracted using the PureLink Genomic DNA Kit (Thermo Fisher Scientific). PCR primers used for additional confirmation of the Vps291 allele (Figure 1B) are listed in the Key Resources Table.
As part of this study, we also generated transgenic strains carrying UAS-dVps29-myc, UAS-dTBC1D5-myc, and UAS-hVps29-FLAG. The full-length Drosophila Vps29 cDNA (Drosophila Genomics Resource Center (DGRC) plasmid: GH25884) was cloned proximal to c-myc coding sequencing, using primers dVps29-myc-F and dVps29-myc-R (Key Resources Table). The full-length cDNA for TBC1D5 (DGRC plasmid: BS16827) was similarly cloned proximal to the c-myc coding sequencing using primers dTBC1D5-myc-F and dTBC1D5-myc-R. The Vps29-myc and TBC1D5-myc PCR products were each digested with BglII and XbaI restriction enzymes (NEB) and ligated to the pUAST-attB vector using T4 ligase (NEB). Plasmids containing FLAG-tagged Human VPS29 cDNAs (OHu00442D, OHu02289D, and OHu05688D, respectively) were obtained from GenScript. For PCR cloning, we used hVps29-R along with each of the following: hVps29-1-F for hVps29 transcript variant 1 (NM_016226.4), hVps29-2-F for hVps29 transcript variant 2 (NM_057180.2), and hVps29-3-F for hVps29 transcript variant 3 (NM_001282150.1). PCR products were digested by XhoI and XbaI restriction enzymes (NEB), and then ligated to the pUAST-attB vector. The resulting constructs were purified, verified by Sanger DNA sequencing, and injected into y,w,ΦC31; VK33 embryos to generate transgenic flies. The generation of w;Vps35TagRFP-T (Vps35RFP) with a Rippase-switchable TagRFP-T to GFP tag was described in Koles et al. (2016). w;Vps35GFP was generated by crossing Vps35RFP to bam-Gal4;;UAS-Rippase::PEST @attP2 flies to isolate germline ripouts of the TagRFP-T cassette, leaving a C-terminal EGFP knockin.
All Drosophila crosses were raised on molasses-based food at 25°C unless otherwise noted. To induce neuronal specific knockdown of Vps35GFP, we used the deGradFP system (Caussinus et al., 2012; Nagarkar-Jaiswal et al., 2015). Crosses were established and maintained at 18°C, and following eclosure, adults were shifted to 29°C for 7 days before brain dissection.
Histology and immunofluorescence
For histology, Drosophila heads were fixed in 8% glutaraldehyde (Electron Microscopy Sciences) at 4°C for 6 days and embedded in paraffin. Frontal (5 μm) sections were cut using a Leica Microtome (RM2245), mounted on slides, and stained with hematoxylin and eosin. For whole mount brain immunostaining, adult fly brains were dissected in 1X PBS and fixed at 4°C overnight in 4% paraformaldehyde in 1X PBS (sc-281692, ChemCruz). Fixed brains were permeabilized with 2% PBST (1X PBS+2% Triton X-100) at 4°C for 20 hr, and then vacuumed (Nalgene) at room temperature for 1 hr. Brains were incubated with the primary antibodies at 4°C for 2 days, followed by secondary antibody incubation for 1 day at 4°C, then mounted in RapiClear (SunJin Lab Co.). For NMJ staining, wandering third instar larvae were dissected in Hemolymph-Like 3 (HL3) solution without calcium (110 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 10 mM MgCl2, 5 mM trehalose, 30 mM sucrose, and 5 mM HEPES, pH 7.2), fixed in 100% methanol at room temperature for 20 min, washed in 0.3% PBST, and blocked for 1 hr in 0.3% PBST containing 5% normal goat serum. Tissues were incubated with primary antibody overnight at 4°C, followed by secondary antibodies at room temperature for 2 hr, and mounted using Vectashield (Vector Laboratories) prior to imaging. All NMJ studies focused on muscles 6/7, abdominal section 2 and 3. To quantify GFP (Vps35) intensity within NMJ synaptic boutons, confocal regions of interest (ROIs) were determined using the Imaris (Bitplane) ‘surface’ tool to select HRP-positive regions. Identical parameters for defining HRP surfaces were applied for all samples. Mean GFP signal intensity within the ROI encompassing the synaptic area was normalized to HRP volume (μm3). For fly retina staining, fly heads were fixed after the removal of proboscis in 3.7% formaldehyde in PBS at 4°C overnight. Fixed retinae were dissected and blocked in 0.1% PBST containing 5% natural donkey serum at room temperature for 1 hr, followed by primary antibody incubation for 2 days at 4°C and secondary antibody incubation for 2 hr at room temperature. Primary antibodies were used at following dilutions in 0.3% PBST: FITC-conjugated anti-GFP (sc-9996 FITC, 1:100, Santa Cruz Biotechnology, RRID:AB_627695), Mouse anti-Rab7 (1:100, DSHB, RRID:AB_2722471), Rat anti-Elav (7E8A10,1:500, DSHB, RRID:AB_528218), Rabbit anti-GlcCer (1:250, Glycobiotech); Cy3-conjugated anti-HRP (1:150, Jackson ImmunoResearch); Rabbit anti-Arl8 (1:1000, DSHB, RRID:AB_2618258); Guinea pig anti-Vps26 (1:500, Wang et al., 2014). For secondary antibodies, we used Cy3-conjugated goat anti-mouse or anti-Rat IgG, and Alexa 647-conjugated goat anti-Rabbit or anti-Guinea pig IgG (1:500, Jackson ImmunoResearch). Confocal microscopy images were acquired with a Model LSM 880 confocal system (Carl Zeiss).
Western blot analysis and immunoprecipitation
For western blots, adult fly heads or whole larvae were homogenized in 2X Laemmli Sample Buffer (Bio-Rad) with 5% β-mercaptoethanol (Calbiochem) using a pestle (Argos Technologies). The lysates were heated at 95°C for 5 min, followed by centrifugation at 21,130 × g at 4°C for 15 min before SDS-PAGE analysis. Samples were loaded into 12% Bis-Tris gels (Invitrogen), separated by SDS-PAGE. For immunoprecipitation of Vps35GFP, 300 fly heads from 1- to 2 day-old animals were homogenized on ice in 700 μL of lysis buffer containing 10 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, and 1X complete protease inhibitor (Roche). Homogenized samples were centrifugated at 21,130 × g for 30 min at 4°C. 3% (by volume) of the supernatant were reserved for total protein input. The remaining supernatant was incubated for 1 hr at 4°C with 50 μL of protein A/G agarose slurry (Thermo Fisher) to reduce non-specific binding. Following pre-clearing, the lysate was incubated for 3 hr at 4°C with 35 μL of GFP-Trap agarose beads (Allele Biotechnology) with mild agitation. The beads were washed three times with lysis buffer, boiled in 70 μL of 2X Laemmli sample buffer (Biorad), and subjected to SDS-PAGE (BOLT12% Bis-Tris Gel, Invitrogen). Gels were transferred to PVDF membrane (Millipore), and blocked in 5% bovine serum albumin (Sigma) in 1X TBST (Tris-buffered saline + 0.1% Tween-20). We used the following primary antibodies and dilutions: mouse anti-tubulin (DM1A, Sigma Aldrich, RRID:AB_477583), 1∶1000; mouse anti-Rab7 (DSHB, RRID:AB_2722471), 1∶1000; Goat anti-Vps29 (LS-C55674, LifeSpan Biosciences, RRID:AB_2214913),1:2000; Guinea pig anti-Vps26 (Wang et al., 2014), 1:2000; Guinea pig anti-Vps35 (see below), 1:2000; Mouse anti-CTSL (clone 193702, MAB22591, R and D Systems, RRID:AB_2087830), 1:2000; Goat anti-CTSD (sc-6487, Santa Cruz, RRID:AB_637895): 1:500, Rabbit anti-p62/Ref(2)p (Rui et al., 2015), 1:2000; Rabbit anti-Atg8 (Castillo-Quan et al., 2016), 1:1000; Mouse anti-GFP (B-2, Santa Cruz, RRID:AB_627695), 1:1000; Mouse anti-actin (C4, Millipore, RRID:AB_2223041), 1:1000; Mouse anti-Polyubiquitinylated proteins (clone FK1, Enzo, RRID:AB_2052280), 1:1000. HRP-conjugated secondary antibodies were used at 1:5000. Antibodies against Drosophila Vps35 were generated by immunization of guinea pigs with a bacterially expressed peptide comprising the C-terminal 338 amino acids of Vps35. Bacterial expression as a GST fusion protein was facilitated by the pGEX 6 P-2 vector. The GST tag was used for protein purification and was cleaved off using PreScission Protease (GE Healthcare Life Sciences) prior to immunization.
Survival and climbing assays
For survival analyses, around 200 flies per genotype (approximately equal numbers of females and males) were aged in groups of no more than 30 flies per vial, transferring to fresh vials and food every 2–3 days. For the startle-induced negative geotaxis assay (climbing), four to five groups consisting of approximately 15 flies each were placed in a plastic cylinder. Flies were gently tapped to the bottom of the cylinder, and locomotor activity was videotaped and quantified as the percentage of animals climbing past the 9 cm line within a 15 s interval.
Electroretinogram (ERG)
All crosses were initially maintained in the dark to prevent flies from being exposed to light before eclosion. Newly-eclosed adults were either shifted to a 12 hr light/dark cycle (3,000 lux for light exposure) or maintained in light-sealed boxes for constant darkness. During aging, the positions of light-exposed vials were randomly shuffled within racks. ERG recordings were performed as previously described (Chouhan et al., 2016). In brief, adult flies were anesthetized and glued to a glass slide, with electrodes placed on the corneal surface and the thorax. Flies were maintained in the dark for at least 1 min prior to stimulation using a train of alternating light/dark pulses. Retinal responses were recorded and analyzed using LabChart software (ADInstruments). At least eight flies were examined for each genotype and timepoint.
NMJ electrophysiology and FM 1–43 dye studies
Animals were dissected at the wandering third instar stage in HL3 buffer (above), without addition of calcium. Electrophysiologic recordings were performed with 0.5 mM extracellular Ca2+ buffer concentrations, as described in Ojelade et al. (2019). Larval motor axons were severed and miniature excitatory junction potentials (mEJPs) were recorded from muscle 6 of abdominal segments A2 and A3 for 2 min. EJPs were evoked at 0.2 Hz. EJPs and mEJPs were analyzed using pClamp6 (Molecular Devices) and Mini Analysis Program (Synaptosoft) software, respectively. High-frequency stimulation was recorded at 10 Hz for 10 min. The recorded EJP data were binned at 0.5 min intervals and normalized to the average EJP. EJP amplitudes were corrected for nonlinear summation as previously described (Martin, 1955). The FM 1–43 dye uptake assay was performed as described in Verstreken et al. (2008). Larval NMJ preparations were stimulated for 2 min in dark conditions using HL3 buffer containing 90 mM K+, 1.5 mM Ca2+, and 4 µM FM 1–43 dye. Larval preparations were subsequently washed five times with HL3 solution (without 90 mM K+ and calcium), and FM dye uptake was imaged using a Leica Sp8 confocal system. Signal intensity of FM dye per bouton was normalized to each bouton area. Six boutons were sampled per animal. For each genotype, 7–11 animals were assayed.
Transmission Electron Microscopy (TEM)
For analysis of adult eye ultrastructure, fly heads were dissected by removing proboscis and air sacs, then severed from the thorax. For analysis of central brain ultrastructure, fly heads were dissected by removing cuticles and eyes to ensure complete penetration of fixative, leaving each head affixed to the thorax. All samples were processed for TEM as previously described (Chouhan et al., 2016) using a Ted Pella Bio Wave processing microwave with vacuum attachment. Briefly, dissected samples were fixed (4% paraformaldehyde, 2% glutaraldehyde, and 0.1 M sodium cacodylate, pH 7.2) at 4°C for 48 hr, and then submerged in 1% osmium tetroxide for 45 min. The fixed samples were dehydrated using an ethanol series followed by propylene oxide, and then embedded using Embed-812 resin (EMS). For brain samples, each head was removed carefully from the thorax prior to embedding. Transverse sections of brains (50 nm) and tangential sections of eyes (50 nm) were prepared with a Leica UC7 microtome, and post-stained with 1% uranyl acetate and 2.5% lead citrate. All TEM images were acquired using a JEOL 1010 Transmission Electron Microscope. TEM images of photoreceptor sections were prepared from three different animals per genotype. TEM images of brain sections were prepared from four animals per genotype. Images were acquired from the dorsal-posterior cortical brain region (Figure 7—figure supplement 1D), including at least 50 cells per brain.
Quantification and statistics
Confocal images were processed and analyzed using ImageJ software (NIH). Sample size for all comparisons is included in each figure legend (also noted above). For survival curves, we performed log-rank test with Bonferroni's correction. For other statistical analysis, we performed two-tailed, unpaired t-tests or Analysis of Variance (ANOVA) followed by Tukey’s post-hoc test for multiple comparisons, as specified in all figure legends. The significance threshold for all analyses was set to p<0.05. Otherwise, results are noted as ‘not significant’ (n.s.). Error bars in all analyses represent the standard error of the mean (SEM).
Acknowledgements
We thank Drs. L Partridge, S Zhang, and PR Hiesinger for providing antibodies and Drosophila stocks. We also thank the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, the Developmental Studies Hybridoma Bank, and FlyBase (Gramates et al., 2017). We thank Y He and L Duraine for research technical support. We are grateful to Drs. M Sardiello, K Venkatachalam, J Botas, and H Zoghbi for feedback and discussions.
Funding Statement
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Contributor Information
Joshua M Shulman, Email: joshua.shulman@bcm.edu.
K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.
K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.
Funding Information
This paper was supported by the following grants:
National Institutes of Health R01AG053960 to Joshua M Shulman.
National Institutes of Health U01AG046161 to Joshua M Shulman.
National Institutes of Health U01AG061357 to Joshua M Shulman.
National Institutes of Health U54AG065187 to Joshua M Shulman.
Burroughs Wellcome Fund Career Award for Medical Scientists to Joshua M Shulman.
National Institutes of Health R01NS103967 to Avital Adah Rodal.
National Institutes of Health U54HD083092 to Joshua M Shulman.
National Institutes of Health P30CA125123 to Joshua M Shulman.
Howard Hughes Medical Institute to Hugo J Bellen.
Robert and Renee Belfer Family Foundation to David Li-Kroeger, Hugo J Bellen.
Alzheimer's Association AARFD-16-442630 to Shamsideen A Ojelade.
Burroughs Wellcome Fund Postdoctoral Enrichment Program Award (BWF-1017399) to Shamsideen A Ojelade.
Additional information
Competing interests
Reviewing editor, eLife.
No competing interests declared.
Author contributions
Conceptualization, Formal analysis, Investigation.
Investigation.
Investigation.
Investigation.
Investigation.
Investigation.
Resources.
Resources.
Resources.
Supervision.
Conceptualization, Supervision, Funding acquisition.
Additional files
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
References
- Appel JR, Ye S, Tang F, Sun D, Zhang H, Mei L, Xiong WC. Increased microglial activity, impaired adult hippocampal neurogenesis, and Depressive-like behavior in microglial VPS35-Depleted mice. The Journal of Neuroscience. 2018;38:5949–5968. doi: 10.1523/JNEUROSCI.3621-17.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babcock MC, Stowers RS, Leither J, Goodman CS, Pallanck LJ. A genetic screen for synaptic transmission mutants mapping to the right arm of chromosome 3 inDrosophila. Genetics. 2003;165:171–183. doi: 10.1093/genetics/165.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bellen HJ, Tong C, Tsuda H. 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nature Reviews Neuroscience. 2010;11:514–522. doi: 10.1038/nrn2839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burd C, Cullen PJ. Retromer: a master conductor of endosome sorting. Cold Spring Harbor Perspectives in Biology. 2014;6:a016774. doi: 10.1101/cshperspect.a016774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Castillo-Quan JI, Li L, Kinghorn KJ, Ivanov DK, Tain LS, Slack C, Kerr F, Nespital T, Thornton J, Hardy J, Bjedov I, Partridge L. Lithium promotes longevity through GSK3/NRF2-Dependent hormesis. Cell Reports. 2016;15:638–650. doi: 10.1016/j.celrep.2016.03.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caussinus E, Kanca O, Affolter M. Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nature Structural & Molecular Biology. 2012;19:117–121. doi: 10.1038/nsmb.2180. [DOI] [PubMed] [Google Scholar]
- Cherry S, Jin EJ, Özel MN, Lu Z, Agi E, Wang D, Jung W-H, Epstein D, Meinertzhagen IA, Chan C-C, Hiesinger PR. Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function. eLife. 2013;2:e01064. doi: 10.7554/eLife.01064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chouhan AK, Guo C, Hsieh YC, Ye H, Senturk M, Zuo Z, Li Y, Chatterjee S, Botas J, Jackson GR, Bellen HJ, Shulman JM. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease. Acta Neuropathologica Communications. 2016;4:62. doi: 10.1186/s40478-016-0333-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choy RW, Park M, Temkin P, Herring BE, Marley A, Nicoll RA, von Zastrow M. Retromer mediates a discrete route of local membrane delivery to dendrites. Neuron. 2014;82:55–62. doi: 10.1016/j.neuron.2014.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins BM, Skinner CF, Watson PJ, Seaman MN, Owen DJ. Vps29 has a phosphoesterase fold that acts as a protein interaction scaffold for retromer assembly. Nature Structural & Molecular Biology. 2005;12:594–602. doi: 10.1038/nsmb954. [DOI] [PubMed] [Google Scholar]
- Cui Y, Carosi JM, Yang Z, Ariotti N, Kerr MC, Parton RG, Sargeant TJ, Teasdale RD. Retromer has a selective function in cargo sorting via endosome transport carriers. Journal of Cell Biology. 2019;218:615–631. doi: 10.1083/jcb.201806153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cullen PJ, Steinberg F. To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nature Reviews Molecular Cell Biology. 2018;19:679–696. doi: 10.1038/s41580-018-0053-7. [DOI] [PubMed] [Google Scholar]
- Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, Sardi SP, Montine TJ, Pallanck LJ. Glucocerebrosidase deficiency in Drosophila results in α-Synuclein-Independent protein aggregation and neurodegeneration. PLOS Genetics. 2016;12:e1005944. doi: 10.1371/journal.pgen.1005944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Vreede G, Schoenfeld JD, Windler SL, Morrison H, Lu H, Bilder D. The scribble module regulates retromer-dependent endocytic trafficking during epithelial polarization. Development. 2014;141:2796–2802. doi: 10.1242/dev.105403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fernandes AC, Uytterhoeven V, Kuenen S, Wang YC, Slabbaert JR, Swerts J, Kasprowicz J, Aerts S, Verstreken P. Reduced synaptic vesicle protein degradation at Lysosomes curbs TBC1D24/sky-induced neurodegeneration. Journal of Cell Biology. 2014;207:453–462. doi: 10.1083/jcb.201406026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Follett J, Bugarcic A, Yang Z, Ariotti N, Norwood SJ, Collins BM, Parton RG, Teasdale RD. Parkinson Disease-linked Vps35 R524W mutation impairs the endosomal association of retromer and induces α-Synuclein aggregation. Journal of Biological Chemistry. 2016;291:18283–18298. doi: 10.1074/jbc.M115.703157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franch-Marro X, Wendler F, Guidato S, Griffith J, Baena-Lopez A, Itasaki N, Maurice MM, Vincent JP. Wingless secretion requires endosome-to-Golgi retrieval of wntless/Evi/Sprinter by the retromer complex. Nature Cell Biology. 2008;10:170–177. doi: 10.1038/ncb1678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuse A, Furuya N, Kakuta S, Inose A, Sato M, Koike M, Saiki S, Hattori N. VPS29-VPS35 intermediate of retromer is stable and may be involved in the retromer complex assembly process. FEBS Letters. 2015;589:1430–1436. doi: 10.1016/j.febslet.2015.04.040. [DOI] [PubMed] [Google Scholar]
- García-Sanz P, Orgaz L, Fuentes JM, Vicario C, Moratalla R. Cholesterol and multilamellar bodies: lysosomal dysfunction in GBA-Parkinson disease. Autophagy. 2018;14:717–718. doi: 10.1080/15548627.2018.1427396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521–533. doi: 10.1016/S0896-6273(02)00682-7. [DOI] [PubMed] [Google Scholar]
- Gramates LS, Marygold SJ, Santos GD, Urbano JM, Antonazzo G, Matthews BB, Rey AJ, Tabone CJ, Crosby MA, Emmert DB, Falls K, Goodman JL, Hu Y, Ponting L, Schroeder AJ, Strelets VB, Thurmond J, Zhou P, the FlyBase Consortium FlyBase at 25: looking to the future. Nucleic Acids Research. 2017;45:D663–D671. doi: 10.1093/nar/gkw1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris KP, Littleton JT. Transmission, development, and plasticity of synapses. Genetics. 2015;201:345–375. doi: 10.1534/genetics.115.176529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hasanagic M, van Meel E, Luan S, Aurora R, Kornfeld S, Eissenberg JC. The lysosomal enzyme receptor protein (LERP) is not essential, but is implicated in lysosomal function in Drosophila melanogaster. Biology Open. 2015;4:1316–1325. doi: 10.1242/bio.013334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hierro A, Rojas AL, Rojas R, Murthy N, Effantin G, Kajava AV, Steven AC, Bonifacino JS, Hurley JH. Functional architecture of the retromer cargo-recognition complex. Nature. 2007;449:1063–1067. doi: 10.1038/nature06216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ihara Y, Morishima-Kawashima M, Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2012;2:a006361. doi: 10.1101/cshperspect.a006361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inoshita T, Arano T, Hosaka Y, Meng H, Umezaki Y, Kosugi S, Morimoto T, Koike M, Chang HY, Imai Y, Hattori N. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila. Human Molecular Genetics. 2017;26:2933–2948. doi: 10.1093/hmg/ddx179. [DOI] [PubMed] [Google Scholar]
- Jia D, Zhang JS, Li F, Wang J, Deng Z, White MA, Osborne DG, Phillips-Krawczak C, Gomez TS, Li H, Singla A, Burstein E, Billadeau DD, Rosen MK. Structural and mechanistic insights into regulation of the retromer coat by TBC1d5. Nature Communications. 2016;7:13305. doi: 10.1038/ncomms13305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jimenez-Orgaz A, Kvainickas A, Nägele H, Denner J, Eimer S, Dengjel J, Steinberg F. Control of RAB7 activity and localization through the retromer-TBC1D5 complex enables RAB7-dependent mitophagy. The EMBO Journal. 2018;37:235–254. doi: 10.15252/embj.201797128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin EJ, Kiral FR, Ozel MN, Burchardt LS, Osterland M, Epstein D, Wolfenberg H, Prohaska S, Hiesinger PR. Live observation of two parallel membrane degradation pathways at axon terminals. Current Biology. 2018;28:1027–1038. doi: 10.1016/j.cub.2018.02.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jongsma ML, Bakker J, Cabukusta B, Liv N, van Elsland D, Fermie J, Akkermans JL, Kuijl C, van der Zanden SY, Janssen L, Hoogzaad D, van der Kant R, Wijdeven RH, Klumperman J, Berlin I, Neefjes J. SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport. The EMBO Journal. 2020;39:e102301. doi: 10.15252/embj.2019102301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karch CM, Cruchaga C, Goate AM. Alzheimer's disease genetics: from the bench to the clinic. Neuron. 2014;83:11–26. doi: 10.1016/j.neuron.2014.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klumperman J, Raposo G. The complex ultrastructure of the endolysosomal system. Cold Spring Harbor Perspectives in Biology. 2014;6:a016857. doi: 10.1101/cshperspect.a016857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koles K, Yeh AR, Rodal AA. Tissue-specific tagging of endogenous loci in Drosophila melanogaster. Biology Open. 2016;5:83–89. doi: 10.1242/bio.016089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Korolchuk VI, Schütz MM, Gómez-Llorente C, Rocha J, Lansu NR, Collins SM, Wairkar YP, Robinson IM, O'Kane CJ. Drosophila Vps35 function is necessary for normal endocytic trafficking and actin cytoskeleton organisation. Journal of Cell Science. 2007;120:4367–4376. doi: 10.1242/jcs.012336. [DOI] [PubMed] [Google Scholar]
- Koumandou VL, Klute MJ, Herman EK, Nunez-Miguel R, Dacks JB, Field MC. Evolutionary reconstruction of the retromer complex and its function in Trypanosoma brucei. Journal of Cell Science. 2011;124:1496–1509. doi: 10.1242/jcs.081596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kovtun O, Leneva N, Bykov YS, Ariotti N, Teasdale RD, Schaffer M, Engel BD, Owen DJ, Briggs JAG, Collins BM. Structure of the membrane-assembled retromer coat determined by cryo-electron tomography. Nature. 2018;561:561–564. doi: 10.1038/s41586-018-0526-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li C, Brazill JM, Liu S, Bello C, Zhu Y, Morimoto M, Cascio L, Pauly R, Diaz-Perez Z, Malicdan MCV, Wang H, Boccuto L, Schwartz CE, Gahl WA, Boerkoel CF, Zhai RG. Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome. Nature Communications. 2017;8:1257. doi: 10.1038/s41467-017-01289-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li-Kroeger D, Kanca O, Lee PT, Cowan S, Lee MT, Jaiswal M, Salazar JL, He Y, Zuo Z, Bellen HJ. An expanded toolkit for gene tagging based on MiMIC and scarless CRISPR tagging in Drosophila. eLife. 2018;7:e38709. doi: 10.7554/eLife.38709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin G, Lee PT, Chen K, Mao D, Tan KL, Zuo Z, Lin WW, Wang L, Bellen HJ. Phospholipase PLA2G6, a Parkinsonism-Associated gene, affects Vps26 and Vps35, retromer function, and ceramide levels, similar to α-Synuclein gain. Cell Metabolism. 2018;28:605–618. doi: 10.1016/j.cmet.2018.05.019. [DOI] [PubMed] [Google Scholar]
- Linhart R, Wong SA, Cao J, Tran M, Huynh A, Ardrey C, Park JM, Hsu C, Taha S, Peterson R, Shea S, Kurian J, Venderova K. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2) Molecular Neurodegeneration. 2014;9:23. doi: 10.1186/1750-1326-9-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu TT, Gomez TS, Sackey BK, Billadeau DD, Burd CG. Rab GTPase regulation of retromer-mediated cargo export during endosome maturation. Molecular Biology of the Cell. 2012;23:2505–2515. doi: 10.1091/mbc.e11-11-0915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu W, Tang FL, Erion J, Xiao H, Ye J, Xiong WC. Vps35 haploinsufficiency results in degenerative-like deficit in mouse retinal ganglion neurons and impairment of optic nerve injury-induced gliosis. Molecular Brain. 2014;7:10. doi: 10.1186/1756-6606-7-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorenowicz MJ, Macurkova M, Harterink M, Middelkoop TC, de Groot R, Betist MC, Korswagen HC. Inhibition of late endosomal maturation restores wnt secretion in Caenorhabditis elegans vps-29 retromer mutants. Cellular Signalling. 2014;26:19–31. doi: 10.1016/j.cellsig.2013.09.013. [DOI] [PubMed] [Google Scholar]
- Lucas M, Gershlick DC, Vidaurrazaga A, Rojas AL, Bonifacino JS, Hierro A. Structural mechanism for cargo recognition by the retromer complex. Cell. 2016;167:1623–1635. doi: 10.1016/j.cell.2016.10.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lucas M, Hierro A. Retromer. Current Biology. 2017;27:R687–R689. doi: 10.1016/j.cub.2017.05.072. [DOI] [PubMed] [Google Scholar]
- Lund VK, Madsen KL, Kjaerulff O. Drosophila Rab2 controls endosome-lysosome fusion and LAMP delivery to late endosomes. Autophagy. 2018;14:1520–1542. doi: 10.1080/15548627.2018.1458170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malik BR, Godena VK, Whitworth AJ. VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin. Human Molecular Genetics. 2015;24:6106–6117. doi: 10.1093/hmg/ddv322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin AR. A further study of the statistical composition on the end-plate potential. The Journal of Physiology. 1955;130:114–122. doi: 10.1113/jphysiol.1955.sp005397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martini-Stoica H, Xu Y, Ballabio A, Zheng H. The Autophagy-Lysosomal pathway in neurodegeneration: a TFEB perspective. Trends in Neurosciences. 2016;39:221–234. doi: 10.1016/j.tins.2016.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maruzs T, Lőrincz P, Szatmári Z, Széplaki S, Sándor Z, Lakatos Z, Puska G, Juhász G, Sass M. Retromer ensures the degradation of autophagic cargo by maintaining lysosome function in Drosophila. Traffic. 2015;16:1088–1107. doi: 10.1111/tra.12309. [DOI] [PubMed] [Google Scholar]
- Marwaha R, Arya SB, Jagga D, Kaur H, Tuli A, Sharma M. The Rab7 effector PLEKHM1 binds Arl8b to promote cargo traffic to lysosomes. Journal of Cell Biology. 2017;216:1051–1070. doi: 10.1083/jcb.201607085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nature Reviews Neuroscience. 2006;7:278–294. doi: 10.1038/nrn1886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McNally KE, Faulkner R, Steinberg F, Gallon M, Ghai R, Pim D, Langton P, Pearson N, Danson CM, Nägele H, Morris LL, Singla A, Overlee BL, Heesom KJ, Sessions R, Banks L, Collins BM, Berger I, Billadeau DD, Burstein E, Cullen PJ. Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling. Nature Cell Biology. 2017;19:1214–1225. doi: 10.1038/ncb3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mecozzi VJ, Berman DE, Simoes S, Vetanovetz C, Awal MR, Patel VM, Schneider RT, Petsko GA, Ringe D, Small SA. Pharmacological chaperones stabilize retromer to limit APP processing. Nature Chemical Biology. 2014;10:443–449. doi: 10.1038/nchembio.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mehta SQ, Hiesinger PR, Beronja S, Zhai RG, Schulze KL, Verstreken P, Cao Y, Zhou Y, Tepass U, Crair MC, Bellen HJ. Mutations in Drosophila sec15 reveal a function in neuronal targeting for a subset of exocyst components. Neuron. 2005;46:219–232. doi: 10.1016/j.neuron.2005.02.029. [DOI] [PubMed] [Google Scholar]
- Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nature Reviews Neuroscience. 2015;16:345–357. doi: 10.1038/nrn3961. [DOI] [PubMed] [Google Scholar]
- Mitter D, Reisinger C, Hinz B, Hollmann S, Yelamanchili SV, Treiber-Held S, Ohm TG, Herrmann A, Ahnert-Hilger G. The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content. Journal of Neurochemistry. 2003;84:35–42. doi: 10.1046/j.1471-4159.2003.01258.x. [DOI] [PubMed] [Google Scholar]
- Muhammad A, Flores I, Zhang H, Yu R, Staniszewski A, Planel E, Herman M, Ho L, Kreber R, Honig LS, Ganetzky B, Duff K, Arancio O, Small SA. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. PNAS. 2008;105:7327–7332. doi: 10.1073/pnas.0802545105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munsie LN, Milnerwood AJ, Seibler P, Beccano-Kelly DA, Tatarnikov I, Khinda J, Volta M, Kadgien C, Cao LP, Tapia L, Klein C, Farrer MJ. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the parkinson's disease VPS35 mutation p.D620N. Human Molecular Genetics. 2015;24:1691–1703. doi: 10.1093/hmg/ddu582. [DOI] [PubMed] [Google Scholar]
- Nagarkar-Jaiswal S, Lee P-T, Campbell ME, Chen K, Anguiano-Zarate S, Cantu Gutierrez M, Busby T, Lin W-W, He Y, Schulze KL, Booth BW, Evans-Holm M, Venken KJT, Levis RW, Spradling AC, Hoskins RA, Bellen HJ. A library of MiMICs allows tagging of genes and reversible, spatial and temporal knockdown of proteins in Drosophila. eLife. 2015;4:e05338. doi: 10.7554/eLife.05338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newsome TP, Asling B, Dickson BJ. Analysis ofDrosophilaphotoreceptor axon guidance in eye-specific mosaics. Development. 2000;127:851–860. doi: 10.1242/dev.127.4.851. [DOI] [PubMed] [Google Scholar]
- Ohara S, Ukita Y, Ninomiya H, Ohno K. Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann-Pick disease type C. Experimental Neurology. 2004;187:289–298. doi: 10.1016/j.expneurol.2004.03.002. [DOI] [PubMed] [Google Scholar]
- Ojelade SA, Lee TV, Giagtzoglou N, Yu L, Ugur B, Li Y, Duraine L, Zuo Z, Petyuk V, De Jager PL, Bennett DA, Arenkiel BR, Bellen HJ, Shulman JM. Cindr, the Drosophila homolog of the CD2AP alzheimer’s Disease Risk Gene, Is Required for Synaptic Transmission and Proteostasis. Cell Reports. 2019;28:1799–1813. doi: 10.1016/j.celrep.2019.07.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piras A, Collin L, Grüninger F, Graff C, Rönnbäck A. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathologica Communications. 2016;4:22. doi: 10.1186/s40478-016-0292-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pocha SM, Wassmer T, Niehage C, Hoflack B, Knust E. Retromer controls epithelial cell polarity by trafficking the apical determinant crumbs. Current Biology. 2011;21:1111–1117. doi: 10.1016/j.cub.2011.05.007. [DOI] [PubMed] [Google Scholar]
- Reddy JV, Seaman MN. Vps26p, a component of retromer, directs the interactions of Vps35p in endosome-to-Golgi retrieval. Molecular Biology of the Cell. 2001;12:3242–3256. doi: 10.1091/mbc.12.10.3242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Repnik U, Česen MH, Turk B. The endolysosomal system in cell death and survival. Cold Spring Harbor Perspectives in Biology. 2013;5:a008755. doi: 10.1101/cshperspect.a008755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosa-Ferreira C, Sweeney ST, Munro S. The small G protein Arl8 contributes to lysosomal function and long-range axonal transport in Drosophila. Biology Open. 2018;7:bio035964. doi: 10.1242/bio.035964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rousseaux MWC, Vázquez-Vélez GE, Al-Ramahi I, Jeong HH, Bajić A, Revelli JP, Ye H, Phan ET, Deger JM, Perez AM, Kim JY, Lavery LA, Xu Q, Li MZ, Kang H, Kim JJ, Shulman JM, Westbrook TF, Elledge SJ, Liu Z, Botas J, Zoghbi HY. A druggable genome screen identifies modifiers of α-Synuclein levels via a tiered Cross-Species validation approach. The Journal of Neuroscience. 2018;38:9286–9301. doi: 10.1523/JNEUROSCI.0254-18.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rui YN, Xu Z, Patel B, Chen Z, Chen D, Tito A, David G, Sun Y, Stimming EF, Bellen HJ, Cuervo AM, Zhang S. Huntingtin functions as a scaffold for selective macroautophagy. Nature Cell Biology. 2015;17:262–275. doi: 10.1038/ncb3101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sambri I, D'Alessio R, Ezhova Y, Giuliano T, Sorrentino NC, Cacace V, De Risi M, Cataldi M, Annunziato L, De Leonibus E, Fraldi A. Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases. EMBO Molecular Medicine. 2017;9:112–132. doi: 10.15252/emmm.201606965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seaman MN, Marcusson EG, Cereghino JL, Emr SD. Endosome to golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. Journal of Cell Biology. 1997;137:79–92. doi: 10.1083/jcb.137.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seaman MN, McCaffery JM, Emr SD. A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. Journal of Cell Biology. 1998;142:665–681. doi: 10.1083/jcb.142.3.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seaman MN, Harbour ME, Tattersall D, Read E, Bright N. Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. Journal of Cell Science. 2009;122:2371–2382. doi: 10.1242/jcs.048686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Small SA, Petsko GA. Retromer in alzheimer disease, parkinson disease and other neurological disorders. Nature Reviews Neuroscience. 2015;16:126–132. doi: 10.1038/nrn3896. [DOI] [PubMed] [Google Scholar]
- Soukup SF, Vanhauwaert R, Verstreken P. Parkinson's disease: convergence on synaptic homeostasis. The EMBO Journal. 2018;37:e98960. doi: 10.15252/embj.201898960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starble R, Pokrywka NJ. The retromer subunit Vps26 mediates notch signaling during Drosophila oogenesis. Mechanisms of Development. 2018;149:1–8. doi: 10.1016/j.mod.2017.10.001. [DOI] [PubMed] [Google Scholar]
- Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005;307:1282–1288. doi: 10.1126/science.1105681. [DOI] [PubMed] [Google Scholar]
- Strutt H, Langton PF, Pearson N, McMillan KJ, Strutt D, Cullen PJ. Retromer controls planar polarity protein levels and asymmetric localization at intercellular junctions. Current Biology. 2019;29:484–491. doi: 10.1016/j.cub.2018.12.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sweeney ST, Davis GW. Unrestricted synaptic growth in spinster-a late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation. Neuron. 2002;36:403–416. doi: 10.1016/S0896-6273(02)01014-0. [DOI] [PubMed] [Google Scholar]
- Tang FL, Erion JR, Tian Y, Liu W, Yin DM, Ye J, Tang B, Mei L, Xiong WC. VPS35 in dopamine neurons is required for Endosome-to-Golgi retrieval of Lamp2a, a receptor of Chaperone-Mediated autophagy that is critical for α-Synuclein degradation and prevention of pathogenesis of Parkinson's Disease. Journal of Neuroscience. 2015a;35:10613–10628. doi: 10.1523/JNEUROSCI.0042-15.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang FL, Liu W, Hu JX, Erion JR, Ye J, Mei L, Xiong WC. VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Reports. 2015b;12:1631–1643. doi: 10.1016/j.celrep.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Temkin P, Morishita W, Goswami D, Arendt K, Chen L, Malenka R. The retromer supports AMPA receptor trafficking during LTP. Neuron. 2017;94:74–82. doi: 10.1016/j.neuron.2017.03.020. [DOI] [PubMed] [Google Scholar]
- Tian Y, Tang FL, Sun X, Wen L, Mei L, Tang BS, Xiong WC. VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation. Molecular Brain. 2015;8:70. doi: 10.1186/s13041-015-0156-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin UM, Lees A, Troncoso JC, Lewis PA, Bandopadhyay R, Schneider BL, Moore DJ. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Human Molecular Genetics. 2014;23:4621–4638. doi: 10.1093/hmg/ddu178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P. Loss of Skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell. 2011;145:117–132. doi: 10.1016/j.cell.2011.02.039. [DOI] [PubMed] [Google Scholar]
- Vagnozzi AN, Li J-G, Chiu J, Razmpour R, Warfield R, Ramirez SH, Praticò D. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Molecular Psychiatry. 2019;34:453. doi: 10.1038/s41380-019-0453-x. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Vazquez-Sanchez S, Bobeldijk S, Dekker MP, van Keimpema L, van Weering JRT. VPS35 depletion does not impair presynaptic structure and function. Scientific Reports. 2018;8:2996. doi: 10.1038/s41598-018-20448-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venken KJ, Carlson JW, Schulze KL, Pan H, He Y, Spokony R, Wan KH, Koriabine M, de Jong PJ, White KP, Bellen HJ, Hoskins RA. Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nature Methods. 2009;6:431–434. doi: 10.1038/nmeth.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verstreken P, Kjaerulff O, Lloyd TE, Atkinson R, Zhou Y, Meinertzhagen IA, Bellen HJ. Endophilin mutations block clathrin-mediated endocytosis but not neurotransmitter release. Cell. 2002;109:101–112. doi: 10.1016/S0092-8674(02)00688-8. [DOI] [PubMed] [Google Scholar]
- Verstreken P, Ohyama T, Bellen HJ. FM 1-43 labeling of synaptic vesicle pools at the Drosophila neuromuscular junction. Methods in Molecular Biology. 2008;440:349–369. doi: 10.1007/978-1-59745-178-9_26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, Hentati F, Krygowska-Wajs A, Lynch T, Melamed E, Rajput A, Rajput AH, Solida A, Wu R-M, Uitti RJ, Wszolek ZK, Vingerhoets F, Farrer MJ. VPS35 mutations in parkinson disease. The American Journal of Human Genetics. 2011;89:162–167. doi: 10.1016/j.ajhg.2011.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh RB, Becalska AN, Zunitch MJ, Wang S, Isaac B, Yeh A, Koles K, Rodal AA. Opposing functions for retromer and Rab11 in extracellular vesicle cargo traffic at synapses. bioRxiv. 2019 doi: 10.1101/645713. [DOI] [PMC free article] [PubMed]
- Wang S, Tan KL, Agosto MA, Xiong B, Yamamoto S, Sandoval H, Jaiswal M, Bayat V, Zhang K, Charng WL, David G, Duraine L, Venkatachalam K, Wensel TG, Bellen HJ. The retromer complex is required for rhodopsin recycling and its loss leads to photoreceptor degeneration. PLOS Biology. 2014;12:e1001847. doi: 10.1371/journal.pbio.1001847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang YC, Lauwers E, Verstreken P. Presynaptic protein homeostasis and neuronal function. Current Opinion in Genetics & Development. 2017;44:38–46. doi: 10.1016/j.gde.2017.01.015. [DOI] [PubMed] [Google Scholar]
- Wang S, Bellen HJ. The retromer complex in development and disease. Development. 2015;142:2392–2396. doi: 10.1242/dev.123737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, Shen C, Jung JU, Xiong F, Lee DH, Zhang QG, Brann D, Kim TW, Yan R, Mei L, Xiong WC. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. The Journal of Cell Biology. 2011;195:765–779. doi: 10.1083/jcb.201105109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winther ÅM, Jiao W, Vorontsova O, Rees KA, Koh TW, Sopova E, Schulze KL, Bellen HJ, Shupliakov O. The dynamin-binding domains of Dap160/intersectin affect bulk membrane retrieval in synapses. Journal of Cell Science. 2013;126:1021–1031. doi: 10.1242/jcs.118968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu S, Fagan RR, Uttamapinant C, Lifshitz LM, Fogarty KE, Ting AY, Melikian HE. The dopamine transporter recycles via a Retromer-Dependent postendocytic mechanism: tracking studies using a novel Fluorophore-Coupling approach. The Journal of Neuroscience. 2017;37:9438–9452. doi: 10.1523/JNEUROSCI.3885-16.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Young JE, Fong LK, Frankowski H, Petsko GA, Small SA, Goldstein LSB. Stabilizing the retromer complex in a human stem cell model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports. 2018;10:1046–1058. doi: 10.1016/j.stemcr.2018.01.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ysselstein D, Shulman JM, Krainc D. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism. Movement Disorders. 2019;34:614–624. doi: 10.1002/mds.27631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zavodszky E, Seaman MN, Moreau K, Jimenez-Sanchez M, Breusegem SY, Harbour ME, Rubinsztein DC. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nature Communications. 2014;5:3828. doi: 10.1038/ncomms4828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH, Offman MN, Haubenberger D, Spielberger S, Schulte EC, Lichtner P, Rossle SC, Klopp N, Wolf E, Seppi K, Pirker W, Presslauer S, Mollenhauer B, Katzenschlager R, Foki T, Hotzy C, Reinthaler E, Harutyunyan A, Kralovics R, Peters A, Zimprich F, Brücke T, Poewe W, Auff E, Trenkwalder C, Rost B, Ransmayr G, Winkelmann J, Meitinger T, Strom TM. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset parkinson disease. The American Journal of Human Genetics. 2011;89:168–175. doi: 10.1016/j.ajhg.2011.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]